OpenLegislation

Annex II

United Kingdom

Original text. Later amendments are not shown.

Index NoInternational Chemical IdentificationEC NoCAS NoClassificationLabellingSpecific Conc. Limits M-factorsNotes
Hazard Class and Category Code(s)Hazard statement Code(s)Pictogram, Signal Word Code(s)Hazard statement Code(s)Suppl. Hazard statement Code(s)
003-003-00-5

(2-methylpropyl)lithium;

isobutyllithium

440-620-2920-36-5

Water-react. 1

Pyr. Liq. 1

Skin Corr. 1A

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H260

H250

H314

H336

H400

H410

GHS02

GHS05

GHS07

GHS09

Dgr

H260

H250

H314

H336

H410

EUH014
005-007-00-2

boric acid; [1]

boric acid, crude natural, containing not more than 85 per cent of H3BO3 calculated on the dry weight [2]

233-139-2 [1]

234-343-4 [2]

10043-35-3 [1]

11113-50-1 [2]

Repr. 1BH360FD

GHS08

Dgr

H360FDRepr. 1B; H360FD: C ≥ 5,5 %
005-008-00-8

diboron trioxide;

boric oxide

215-125-81303-86-2Repr. 1BH360FD

GHS08

Dgr

H360FDRepr. 1B; H360FD: C ≥ 3,1 %
005-011-00-4

disodium tetraborate, anhydrous;

boric acid, disodium salt; [1]

tetraboron disodium heptaoxide, hydrate; [2]

orthoboric acid, sodium salt [3]

215-540-4 [1]

235-541-3 [2]

237-560-2 [3]

1330-43-4 [1]

12267-73-1 [2]

13840-56-7 [3]

Repr. 1BH360FD

GHS08

Dgr

H360FDRepr. 1B; H360FD: C ≥ 4,5 %
005-011-01-1

disodium tetraborate decahydrate;

borax decahydrate

215-540-41303-96-4Repr. 1BH360FD

GHS08

Dgr

H360FDRepr. 1B; H360FD: C ≥ 8,5 %
005-011-02-9

disodium tetraborate pentahydrate;

borax pentahydrate

215-540-412179-04-3Repr. 1BH360FD

GHS08

Dgr

H360FDRepr. 1B; H360FD: C ≥ 6,5 %
005-013-00-5diethylmethoxyborane425-380-97397-46-8

Pyr. Liq. 1

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 4

H250

H332

H312

H302

H373**

H314

H317

H413

GHS02

GHS05

GHS08

GHS07

Dgr

H250

H332

H312

H302

H373**

H314

H317

H413

005-014-00-04-formylphenylboronic acid438-670-587199-17-5Skin Sens. 1H317

GHS07

Wng

H317
005-015-00-61-chloromethyl-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)414-380-4140681-55-6

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

005-016-00-1tetrabutylammonium butyl tris-(4-tert-butylphenyl)borate431-370-5—Aquatic Chronic 4H413—H413
005-017-00-7

sodium perborate; [1]

sodium peroxometaborate; [2]

sodium peroxoborate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

239-172-9 [1]

231-556-4 [2]

15120-21-5 [1]

7632-04-4 [2]

Oxid. Sol. 2

Repr. 1B

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H302

H335

H318

GHS03

GHS05

GHS08

GHS07

Dgr

H272

H360Df

H302

H335

H318

Repr. 1B; H360Df: C ≥ 9 %

Repr. 1B; H360D: 6,5 % ≤ C < 9 %

Eye Dam. 1; H318: C ≥ 22 %

Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-017-01-4

sodium perborate; [1]

sodium peroxometaborate; [2]

sodium peroxoborate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

239-172-9 [1]

231-556-4 [2]

15120-21-5 [1]

7632-04-4 [2]

Oxid. Sol. 2

Repr. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H331

H302

H335

H318

GHS03

GHS06

GHS05

GHS08

Dgr

H272

H360Df

H331

H302

H335

H318

Repr. 1B; H360Df: C ≥ 9 %

Repr. 1B; H360D: 6,5 % ≤ C < 9 %

Eye Dam. 1; H318: C ≥ 22 %

Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-018-00-2

perboric acid (H3BO2(O2)), monosodium salt trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

239-172-9 [1]

234-390-0 [2]

231-556-4 [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. 1B

STOT SE 3

Eye Dam. 1

H360Df

H335

H318

GHS05

GHS08

GHS07

Dgr

H360Df

H335

H318

Repr. 1B; H360 Df: C ≥ 14 %

Repr. 1B; H360D: 10 % ≤ C < 14 %

Eye Dam. 1; H318: C ≥ 36 %

Eye Irrit. 2; H319: 22 % ≤ C < 36 %

005-018-01-X

perboric acid (H3BO2(O2)), monosodium salt, trihydrate; [1]

perboric acid, sodium salt, tetrahydrate; [2]

perboric acid (HBO(O2)), sodium salt, tetrahydrate; [3]

sodium peroxoborate hexahydrate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

239-172-9 [1]

234-390-0 [2]

231-556-4 [3]

13517-20-9 [1]

37244-98-7 [2]

10486-00-7 [3]

Repr. 1B

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H360Df

H332

H335

H318

GHS05

GHS08

GHS07

Dgr

H360Df

H332

H335

H318

Repr. 1B; H360 Df: C ≥ 14 %

Repr. 1B; H360D: 10 % ≤ C < 14 %

Eye Dam. 1; H318: C ≥ 36 %

Eye Irrit. 2; H319: 22 % ≤ C < 36 %

005-019-00-8

perboric acid, sodium salt; [1]

perboric acid, sodium salt, monohydrate; [2]

perboric acid (HBO(O2)), sodium salt, monohydrate; [3]

sodium peroxoborate;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

234-390-0 [1]

234-390-0 [2]

231-556-4 [3]

11138-47-9 [1]

12040-72-1 [2]

10332-33-9 [3]

Oxid. Sol. 3

Repr. 1B

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H302

H335

H318

GHS03

GHS05

GHS08

GHS07

Dgr

H272

H360Df

H302

H335

H318

Repr. 1B; H360Df: C ≥ 9 %

Repr. 1B; H360D: 6,5 % ≤ C < 9 %

Eye Dam. 1; H318: C ≥ 22 %

Eye Irrit. 2; H319: 14 % ≤ C < 22 %

005-019-01-5

perboric acid, sodium salt; [1]

perboric acid, sodium salt, monohydrate; [2]

perboric acid (HBO(O2)), sodium salt, monohydrate; [3]

sodium peroxoborate;

[containing ≥ 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

234-390-0 [1]

234-390-0 [2]

231-556-4 [3]

11138-47-9 [1]

12040-72-1 [2]

10332-33-9 [3]

Oxid. Sol. 3

Repr. 1B

Acute Tox. 3 *

Acute Tox. 4 *

STOT SE 3

Eye Dam. 1

H272

H360Df

H331

H302

H335

H318

GHS03

GHS06

GHS05

GHS08

Dgr

H272

H360Df

H331

H302

H335

H318

Repr. 1B; H360Df: C ≥ 9 %

Repr. 1B; H360D: 6,5 % ≤ C < 9 %

Eye Dam. 1; H318: C ≥ 22 %

Eye Irrit. 2; H319: 14 % ≤ C < 22 %

006-091-00-3

propineb (ISO);

polymeric zinc propylenebis(dithiocarbamate)

—9016-72-2

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

H332

H373**

H317

H400

GHS08

GHS07

GHS09

Wng

H332

H373**

H317

H400

006-092-00-9 tert-butyl (1S)-N-[1-((2S)-2-oxiranyl)-2-phenylethyl]carbamate425-420-598737-29-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
006-093-00-42,2'-dithio di(ethylammonium)-bis(dibenzyldithiocarbamate)427-180-7—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

006-094-00-X O-isobutyl-N-ethoxy carbonylthiocarbamate434-350-4103122-66-3

Flam. Liq. 3

Carc. 1B

Muta. 1B

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H226

H350

H340

H302

H373**

H317

H411

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H350

H340

H302

H373**

H317

H411

006-095-00-5

fosetyl-aluminium (ISO);

aluminium triethyl triphosphonate

254-320-239148-24-8Eye Dam. 1H318

GHS05

Dgr

H318
006-096-00-0

chlorpropham (ISO);

isopropyl 3-chlorocarbanilate

202-925-7101-21-3

Carc. 2

STOT RE 2 *

Aquatic Chronic 2

H351

H373**

H411

GHS08

GHS09

Wng

H351

H373**

H411

006-097-00-61-phenyl-3-(p-toluenesulfonyl)urea424-620-113909-63-2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373**

H412

GHS08

GHS07

Wng

H302

H373**

H412

006-098-00-1 tert-butyl (1R, 5S)-3-azabicyclo[3.1.0]hex-6-ylcarbamate429-170-8134575-17-0

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H302

H373**

H318

H317

GHS05

GHS08

GHS07

Dgrg

H302

H373**

H318

H317

006-099-00-7

N-(p-toluenesulfonyl)-N'-(3-(p-toluenesulfonyloxy)phenyl)urea;

3-({][}(4-methylphenyl)sulfonyl{]carbamoyl[}amino)phenyl 4-methylbenzenesulfonate

520-2232938-43-1Aquatic Chronic 2H411GHS09H411
006-101-00-6

reaction mass of: N,N''-(methylenedi-4,1-phenylene)bis[N'-phenylurea];

N-(4-[[4-[[(phenylamino)carbonyl]amino]phenylmethyl]phenyl]-N'-cyclohexylurea;

N,N''-(methylenedi-4,1-phenylene)bis[N'-cyclohexylurea]

423-070-8—Aquatic Chronic 4H413—H413
006-102-00-1 O-hexyl-N-ethoxycarbonylthiocarbamate432-750-3—

Carc. 1B

Muta. 1B

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H350

H340

H302

H373**

H317

H411

GHS08

GHS07

GHS09

Dgr

H350

H340

H302

H373**

H317

H411

006-103-00-7 N,N''-(methylenedi-4,1-phenylene)bis[N'-octyl]urea445-760-8—

Eye Dam. 1

Resp. Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H334

H400

H410

GHS05

GHS08

GHS09

Dgr

H318

H334

H410

M=100
007-028-00-2hydroxylammonium nitrate236-691-213465-08-2

Expl. 1.1 ****

Carc. 2

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H201

H351

H311

H302

H373**

H319

H315

H317

H400

GHS01

GHS06

GHS08

GHS09

Dgr

H201

H351

H311

H302

H373**

H319

H315

H317

H400

007-029-00-8diethyldimethylammonium hydroxide419-400-595500-19-9

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1A

H312

H302

H314

GHS05

GHS07

Dgr

H312

H302

H314

012-004-00-Xaluminium-magnesium-carbonate-hydroxide-perchlorate-hydrate422-150-1—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
013-010-00-5hydroxy aluminium bis(2,4,8,10-tetra-tert-butyl-6-hydroxy-12H-dibenzo[d,g][1.3.2]dioxaphosphocin-6-oxide)430-650-4151841-65-5Aquatic Chronic 2H411GHS09H411
014-033-00-32-methyl-3-(trimethoxysilyl)propyl-2-propenoate hydrolysis product with silica419-030-4125804-20-8

Flam. Liq. 2

Eye Irrit. 2

STOT SE 3

H225

H319

H336

GHS02

GHS07

Dgr

H225

H319

H336

014-034-00-93-hexylheptamethyltrisiloxane428-700-51873-90-1

Acute Tox. 4 *

Aquatic Chronic 4

H332

H413

GHS07

Wng

H332

H413

014-035-00-42-(3,4-epoxycyclohexyl)ethyltriethoxy silane425-050-410217-34-2

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

014-036-00-X(4-ethoxyphenyl)(3-(4-fluoro-3-phenoxyphenyl)propyl)dimethylsilane405-020-7105024-66-6

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360F***

H400

H410

GHS08

GHS09

Dgr

H360F***

H410

M=1000
014-037-00-52-butanone-O,O',O''-(phenylsilylidyne)trioxime433-360-634036-80-1

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H373**

H317

H412

GHS08

GHS07

Wng

H373**

H317

H412

014-038-00-0 S-(3-(triethoxysilyl)propyl) octanethioate436-690-9220727-26-4Skin Sens. 1H317

GHS07

Wng

H317
014-039-00-6(2,3-dimethylbut-2-yl)-trimethoxysilane439-360-2142877-45-0

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H315

H318

H412

GHS05

Dgr

H315

H318

H412

014-041-00-7 N,N-bis(trimethylsilyl)aminopropylmethyldiethoxysilane445-890-5201290-01-9

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

014-042-00-2reaction mass of: O,O',O'',O'''-silanetetrayl tetrakis(4-methyl-2-pentanone oxime) (3 stereoisomers)423-010-0—Eye Dam. 1H318

GHS05

Dgr

H318
014-043-00-8reaction product of amorphous silica (50-85 %), butyl (1-methylpropyl) magnesium (3-15 %), tetraethyl orthosilicate (5-15 %) and titanium tetrachloride (5-20 %)432-200-2—Aquatic Chronic 2H411GHS09H411
014-044-00-33-[(4'-acetoxy-3'-methoxyphenyl) propyl]trimethoxysilane433-050-0—Aquatic Chronic 2H411GHS09H411
014-045-00-9magnesium sodium fluoride silicate442-650-1—STOT RE 2 *H373**

GHS08

Wng

H373**
015-113-00-0

tolclofos-methyl (ISO);

O-(2,6-dichloro-p-tolyl)-O,O-dimethyl thiophosphate

260-515-357018-04-9

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

015-182-00-7tetraisopropyldichloromethylenebisphosphonate430-630-510596-22-2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H302

H319

H317

GHS06

Wng

H302

H319

H317

015-183-00-2(1-hydroxydodecylidene)diphosphonic acid425-230-216610-63-2

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

015-188-00-X(1-methylethylidene)di-4,1-phenylenetetraphenyl diphosphate425-220-85945-33-5Aquatic Chronic 4H413—H413
015-190-00-0

bis(2,4-dicumylphenyl) neopentyl diphosphite;

3,9-bis[2,4-bis(1-methyl-1-phenylethyl)phenoxy]-2,4,8,10-tetraoxa-3,9-diphosphaspiro[5.5]undecane

421-920-2154862-43-8Aquatic Chronic 4H413—H413
015-191-00-6dodecyldiphenyl phosphate431-760-527460-02-2

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

015-192-00-1tetrakis(2,6-dimethylphenyl)-m-phenylene biphosphate432-770-2139189-30-3

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

015-193-00-7triphenyl(phenylmethyl)phosphonium 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-1-butanesulfonamide (1:1)442-960-7332350-93-3

Acute Tox. 3 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H318

H400

H410

GHS05

GHS06

GHS09

Dgr

H301

H318

H410

015-194-00-2tetrabutyl-phosphonium nonafluoro-butane-1-sulfonate444-440-5220689-12-3

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

015-195-00-8

reaction mass of: potassium o-toluenephosphonate;

potassium m-toluenephosphonate;

potassium p-toluenephosphonate

433-860-4—

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H319

H317

H412

GHS07

Wng

H319

H317

H412

015-196-00-3

reaction mass of: dimethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

diethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate;

methyl ethyl (2-(hydroxymethylcarbamoyl)ethyl)phosphonate

435-960-3—

Carc. 1B

Muta. 1B

Skin Sens. 1

H350

H340

H317

GHS08

GHS07

Dgr

H350

H340

H317

015-197-00-9bis(2,4,4-trimethylpentyl)dithiophosphonic acid420-160-9107667-02-7

Flam. Liq. 3

Acute Tox. 3 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H226

H331

H302

H314

H411

GHS02

GHS06

GHS05

GHS09

Dgr

H226

H331

H302

H314

H411

015-198-00-4(4-phenylbutyl)phosphinic acid420-450-586552-32-1

Carc. 2

Eye Dam. 1

H351

H318

GHS05

GHS08

Dgr

H351

H318

016-092-00-0

reaction mass of: 4,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;

4,8-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol;

5,7-bis(mercaptomethyl)-3,6,9-trithia-1,11-undecanedithiol

427-050-1—

Repr. 1A

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f

H315

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H361f

H315

H317

H410

016-094-00-1sulfur231-722-67704-34-9Skin Irrit. 2H315

GHS07

Wng

H315
016-097-00-81-amino-2-methyl-2-propanethiol hydrochloride434-480-132047-53-3

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H302

H314

H317

H412

GHS05

GHS07

Dgr

H302

H314

H317

H412

017-023-00-7[phosphinyldynetris(oxy)] tris[3-aminopropyl-2-hydroxy-N,N-dimethyl-N-(C6-18)-alkyl] trichlorides425-520-9197179-61-6

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

022-004-00-1potassium titanium oxide (K2Ti6O13)432-240-012056-51-8Carc. 2H351

GHS08

Dgr

H351
022-005-00-7[N-(1,1-dimethylethyl)-1,1-dimethyl-1-[(1,2,3,4,5-η)-2,3,4,5-tetramethyl-2,4-cyclopentadien-1-yl]silanaminato(2-)-κN][(1,2,3,4-η)-1,3-pentadiene]-titanium419-840-8169104-71-6

Flam. Sol. 1****

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 4

H228

H314

H317

H413

GHS02

GHS05

GHS07

Dgr

H228

H314

H317

H413

024-021-00-Xpotassium tetrasodium bis[(N,N'-n)-1'-(phenylcarbamoyl)-3,5-disulfonatobenzeneazo-1'-prop-1'-ene-2,2'-diolato]chromate(III)425-830-4—Eye Dam. 1H318

GHS05

Dgr

H318
026-003-00-7iron (II) sulfate231-753-57720-78-7

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H302

H319

H315

GHS07

Wng

H302

H319

H315

026-003-01-4

iron (II) sulfate (1:1) heptahydrate;

sulfuric acid, iron(II) salt (1:1), heptahydrate;

ferrous sulfate heptahydrate

231-753-57782-63-0

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

H302

H319

H315

GHS07

Wng

H302

H319

H315

Skin Irrit. 2; H315: C ≥ 25 %
026-004-00-2potassium ferrite430-010-412160-44-0

Skin Corr. 1B

Skin Sens. 1

H314

H317

GHS05

GHS07

Dgr

H314

H317

027-006-00-6cobalt acetate200-755-871-48-7

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360F***

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360F***

H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01 %

M=10

1
027-007-00-1zinc hexacyanocobaltate(III), tertiary butyl alcohol/polypropylene glycol complex425-240-7—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

027-008-00-7complex of cobalt(III)-bis(N-phenyl-4-(5-ethylsulfonyl-2-hydroxyphenylazo)-3-hydroxynaphthylamide), hydrated (n H2O,2<n<3)427-390-9—Skin Sens. 1H317

GHS07

Wng

H317
027-009-00-2cobalt nitrate233-402-110141-05-6

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360F***

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360F***

H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01 %

M=10

1
027-010-00-8cobalt carbonate208-169-4513-79-1

Carc. 1B

Muta. 2

Repr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360F***

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360F***

H334

H317

H410

Carc. 1B; H350i: C ≥ 0,01 %

M=10

1
028-002-01-4

nickel powder;

[particle diameter < 1 mm]

231-111-47440-02-0

Carc. 2

STOT RE 1

Skin Sens. 1

Aquatic Chronic 3

H351

H372**

H317

H412

GHS08

GHS07

Dgr

H351

H372**

H317

H412

028-011-00-6nickel dichloride231-743-07718-54-9

Carc. 1A

Muta. 2

Repr. 1B

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H331

H301

H372**

H315

H334

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H350i

H341

H360D***

H331

H301

H372**

H315

H334

H317

H410

STOT RE. 1; H373: C ≥ 1 %

STOT RE. 2; H373: 0,1 % < C < 1 %

Skin Irrit. 2; H315: C ≥ 20 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

028-012-00-1

nickel dinitrate; [1]

nitric acid, nickel salt [2]

236-068-5 [1]

238-076-4 [2]

13138-45-9 [1]

14216-75-2 [2]

Ox. Sol. 2

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H272

H350i

H341

H360D***

H372**

H332

H302

H318

H315

H317

H400

H410

GHS03

GHS05

GHS08

GHS07

GHS09

Dgr

H272

H350i

H341

H360D***

H372**

H332

H302

H318

H315

H317

H410

STOT RE. 1; H373: C ≥ 1 %

STOT RE. 2; H373: 0,1 % < C < 1 %

Skin Irrit. 2; H315: C ≥ 20 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

028-013-00-7nickel matte273-749-669012-50-6

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-014-00-2slimes and sludges, copper electrolytic refining, decopperised, nickel sulfate295-859-392129-57-2

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H332

H302

H315

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D***

H372**

H332

H302

H315

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

028-015-00-8slimes and sludges, copper electrolyte refining, decopperised305-433-194551-87-8

Carc. 1A

Muta. 2

Repr. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

H
028-016-00-3

nickel diperchlorate;

perchloric acid, nickel(II) salt

237-124-113637-71-3

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H314

H334

H317

H400

H410

GHS05

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H314

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-017-00-9

nickel dipotassium bis(sulfate); [1]

diammonium nickel bis(sulfate) [2]

237-563-9 [1]

239-793-2 [2]

13842-46-1 [1]

15699-18-0 [2]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H332

H302

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D***

H372**

H332

H302

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-018-00-4

nickel bis(sulfamidate);

nickel sulfamate

237-396-113770-89-3

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-019-00-Xnickel bis(tetrafluoroborate)238-753-414708-14-6

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-021-00-0

nickel diformate; [1]

formic acid, nickel salt; [2]

formic acid, copper nickel salt [3]

222-101-0 [1]

239-946-6 [2]

268-755-0 [3]

3349-06-2 [1]

15843-02-4 [2]

68134-59-8 [3]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-022-00-6

nickel di(acetate); [1]

nickel acetate [2]

206-761-7 [1]

239-086-1 [2]

373-02-4 [1]

14998-37-9 [2]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H332

H302

H334

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H341

H360D***

H372**

H332

H302

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

E H
028-024-00-7nickel dibenzoate209-046-8553-71-9

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-025-00-2nickel bis(4-cyclohexylbutyrate)223-463-23906-55-6

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

028-026-00-8

nickel(II) stearate;

nickel(II) octadecanoate

218-744-12223-95-2

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-027-00-3nickel dilactate—16039-61-5

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-028-00-9nickel(II) octanoate225-656-74995-91-9

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H314

H334

H317

H400

H410

GHS05

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H314

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-029-00-4

nickel difluoride; [1]

nickel dibromide; [2]

nickel diiodide; [3]

nickel potassium fluoride [4]

233-071-3 [1]

236-665-0 [2]

236-666-6 [3]

- [4]

10028-18-9 [1]

13462-88-9 [2]

13462-90-3 [3]

11132-10-8 [4]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-030-00-Xnickel hexafluorosilicate247-430-726043-11-8

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-031-00-5nickel selenate239-125-215060-62-5

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-032-00-0

nickel hydrogen phosphate; [1]

nickel bis(dihydrogen phosphate); [2]

trinickel bis(orthophosphate); [3]

dinickel diphosphate; [4]

nickel bis(phosphinate); [5]

nickel phosphinate; [6]

phosphoric acid, calcium nickel salt; [7]

diphosphoric acid, nickel(II) salt [8]

238-278-2 [1]

242-522-3 [2]

233-844-5 [3]

238-426-6 [4]

238-511-8 [5]

252-840-4 [6]

- [7]

- [8]

14332-34-4 [1]

18718-11-1 [2]

10381-36-9 [3]

14448-18-1 [4]

14507-36-9 [5]

36026-88-7 [6]

17169-61-8 [7]

19372-20-4 [8]

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372**

H334

H317

H410

H
028-033-00-6diammonium nickel hexacyanoferrate—74195-78-1

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372**

H334

H317

H410

H
028-034-00-1nickel dicyanide209-160-8557-19-7

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372**

H334

H317

H410

EUH032H
028-035-00-7nickel chromate238-766-514721-18-7

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372**

H334

H317

H410

H
028-036-00-2

nickel(II) silicate; [1]

dinickel orthosilicate; [2]

nickel silicate (3:4); [3]

silicic acid, nickel salt; [4]

trihydrogen hydroxybis[orthosilicato(4-)]trinickelate(3-) [5]

244-578-4 [1]

237-411-1 [2]

250-788-7 [3]

253-461-7 [4]

235-688-3 [5]

21784-78-1 [1]

13775-54-7 [2]

31748-25-1 [3]

37321-15-6 [4]

12519-85-6 [5]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-037-00-8dinickel hexacyanoferrate238-946-314874-78-3

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-038-00-3

trinickel bis(arsenate);

nickel(II) arsenate

236-771-713477-70-8

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350

H372**

H317

H410

H
028-039-00-9

nickel oxalate; [1]

oxalic acid, nickel salt [2]

208-933-7 [1]

243-867-2 [2]

547-67-1 [1]

20543-06-0 [2]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-040-00-4nickel telluride235-260-612142-88-0

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-041-00-Xtrinickel tetrasulfide—12137-12-1

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-042-00-5trinickel bis(arsenite)—74646-29-0

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-043-00-0

cobalt nickel gray periclase;

C.I. Pigment Black 25;

C.I. 77332; [1]

cobalt nickel dioxide; [2]

cobalt nickel oxide [3]

269-051-6 [1]

261-346-8 [2]

- [3]

68186-89-0 [1]

58591-45-0 [2]

12737-30-3 [3]

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372**

H317

GHS08

GHS07

Dgr

H350i

H372**

H317

H
028-044-00-6

nickel tin trioxide;

nickel stannate

234-824-912035-38-0

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372**

H317

GHS08

GHS07

Dgr

H350i

H372**

H317

H
028-045-00-1nickel triuranium decaoxide239-876-615780-33-3

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372**

H317

GHS08

GHS07

Dgr

H350i

H372**

H317

H
028-046-00-7nickel dithiocyanate237-205-113689-92-4

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

EUH032

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-047-00-2nickel dichromate239-646-515586-38-6

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-048-00-8nickel(II) selenite233-263-710101-96-9

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372**

H334

H317

H410

H
028-049-00-3nickel selenide215-216-21314-05-2

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-050-00-9silicic acid, lead nickel salt—68130-19-8

Carc. 1A

Repr. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H360Df

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H360Df

H372**

H317

H410

H
028-051-00-4

nickel diarsenide; [1]

nickel arsenide [2]

235-103-1 [1]

248-169-1 [2]

12068-61-0 [1]

27016-75-7 [2]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-052-00-X

nickel barium titanium primrose priderite;

C.I. Pigment Yellow 157;

C.I. 77900

271-853-668610-24-2

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372**

H317

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H
028-053-00-5

nickel dichlorate; [1]

nickel dibromate; [2]

ethyl hydrogen sulfate, nickel(II) salt [3]

267-897-0 [1]

238-596-1 [2]

275-897-7 [3]

67952-43-6 [1]

14550-87-9 [2]

71720-48-4 [3]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %1

M=1

H
028-054-00-0

nickel(II) trifluoroacetate; [1]

nickel(II) propionate; [2]

nickel bis(benzenesulfonate); [3]

nickel(II) hydrogen citrate; [4]

citric acid, ammonium nickel salt; [5]

citric acid, nickel salt; [6]

nickel bis(2-ethylhexanoate); [7]

2-ethylhexanoic acid, nickel salt; [8]

dimethylhexanoic acid nickel salt; [9]

nickel(II) isooctanoate; [10]

nickel isooctanoate; [11]

nickel bis(isononanoate); [12]

nickel(II) neononanoate; [13]

nickel(II) isodecanoate; [14]

nickel(II) neodecanoate; [15]

neodecanoic acid, nickel salt; [16]

nickel(II) neoundecanoate; [17]

bis(d-gluconato-O 1,O 2)nickel; [18]

nickel 3,5-bis(tert-butyl)-4-hydroxybenzoate (1:2); [19]

nickel(II) palmitate; [20]

(2-ethylhexanoato-O)(isononanoato-O)nickel; [21]

(isononanoato-O)(isooctanoato-O)nickel; [22]

(isooctanoato-O)(neodecanoato-O)nickel; [23]

(2-ethylhexanoato-O)(isodecanoato-O)nickel; [24]

(2-ethylhexanoato-O)(neodecanoato-O)nickel; [25]

(isodecanoato-O)(isooctanoato-O)nickel; [26]

(isodecanoato-O)(isononanoato-O)nickel; [27]

(isononanoato-O)(neodecanoato-O)nickel; [28]

fatty acids, C6-19-branched, nickel salts; [29]

fatty acids, C8-18 and C18-unsaturated, nickel salts; [30]

2,7-naphthalenedisulfonic acid, nickel(II) salt; [31]

240-235-8 [1]

222-102-6 [2]

254-642-3 [3]

242-533-3 [4]

242-161-1 [5]

245-119-0 [6]

224-699-9 [7]

231-480-1 [8]

301-323-2 [9]

249-555-2 [10]

248-585-3 [11]

284-349-6 [12]

300-094-6 [13]

287-468-1 [14]

287-469-7 [15]

257-447-1 [16]

300-093-0 [17]

276-205-6 [18]

258-051-1 [19]

237-138-8 [20]

287-470-2 [21]

287-471-8 [22]

284-347-5 [23]

284-351-7 [24]

285-698-7 [25]

285-909-2 [26]

284-348-0 [27]

287-592-6 [28]

294-302-1 [29]

283-972-0 [30]

- [31]

16083-14-0 [1]

3349-08-4 [2]

39819-65-3 [3]

18721-51-2 [4]

18283-82-4 [5]

22605-92-1 [6]

4454-16-4 [7]

7580-31-6 [8]

93983-68-7 [9]

29317-63-3 [10]

27637-46-3 [11]

84852-37-9 [12]

93920-10-6 [13]

85508-43-6 [14]

85508-44-7 [15]

51818-56-5 [16]

93920-09-3 [17]

71957-07-8 [18]

52625-25-9 [19]

13654-40-5 [20]

85508-45-8 [21]

85508-46-9 [22]

84852-35-7 [23]

84852-39-1 [24]

85135-77-9 [25]

85166-19-4 [26]

84852-36-8 [27]

85551-28-6 [28]

91697-41-5 [29]

84776-45-4 [30]

72319-19-8 [31]

Carc. 1A

Muta. 2

Repr. 1B

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H341

H360D***

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H341

H360D***

H372**

H334

H317

H410

STOT RE 1; H372: C ≥ 1 %

STOT RE 2; H373: 0,1 % ≤ C < 1 %

Skin Sens. 1; H317: C ≥ 0,01 %

M=1

H
028-055-00-6

nickel(II) sulfite; [1]

nickel tellurium trioxide; [2]

nickel tellurium tetraoxide; [3]

molybdenum nickel hydroxide oxide phosphate [4]

231-827-7 [1]

239-967-0 [2]

239-974-9 [3]

268-585-7 [4]

7757-95-1 [1]

15851-52-2 [2]

15852-21-8 [3]

68130-36-9 [4]

Carc. 1A

STOT RE 1

Resp. Sens. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H334

H317

H400

H410

GHS08

GHS09

Dgr

H350i

H372**

H334

H317

H410

H
028-056-00-1

nickel boride (NiB); [1]

dinickel boride; [2]

trinickel boride; [3]

nickel boride; [4]

dinickel silicide; [5]

nickel disilicide; [6]

dinickel phosphide; [7]

nickel boron phosphide [8]

234-493-0 [1]

234-494-6 [2]

234-495-1 [3]

235-723-2 [4]

235-033-1 [5]

235-379-3 [6]

234-828-0 [7]

- [8]

12007-00-0 [1]

12007-01-1 [2]

12007-02-2 [3]

12619-90-8 [4]

12059-14-2 [5]

12201-89-7 [6]

12035-64-2 [7]

65229-23-4 [8]

Carc. 1A

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H372**

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H350i

H372**

H317

H410

H
028-057-00-7

dialuminium nickel tetraoxide; [1]

nickel titanium trioxide; [2]

nickel titanium oxide; [3]

nickel divanadium hexaoxide; [4]

cobalt dimolybdenum nickel octaoxide; [5]

nickel zirkonium trioxide; [6]

molybdenum nickel tetraoxide; [7]

nickel tungsten tetraoxide; [8]

olivine, nickel green; [9]

lithium nickel dioxide; [10]

molybdenum nickel oxide; [11]

234-454-8 [1]

234-825-4 [2]

235-752-0 [3]

257-970-5 [4]

268-169-5 [5]

274-755-1 [6]

238-034-5 [7]

238-032-4 [8]

271-112-7 [9]

- [10]

- [11]

12004-35-2 [1]

12035-39-1 [2]

12653-76-8 [3]

52502-12-2 [4]

68016-03-5 [5]

70692-93-2 [6]

14177-55-0 [7]

14177-51-6 [8]

68515-84-4 [9]

12031-65-1 [10]

12673-58-4 [11]

Carc. 1A

STOT RE 1

Skin Sens. 1

H350i

H372**

H317

GHS08

GHS07

Dgr

H350i

H372**

H317

H
028-058-00-2cobalt lithium nickel oxide442-750-5—

Carc. 1A

Acute Tox. 2 *

STOT RE 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H350i

H330

H372**

H317

H400

H410

GHS06

GHS08

GHS09

Dgr

H350i

H330

H372**

H317

H410

029-014-00-5

reaction mass of: 2,2'-[[cis-1,2-cyclohexanediylbis(nitrilomethylidene)]bis[phenolate]](2-)N,N',O,O'-copper complex;

2,2'-[[trans-1,2-cyclohexanediylbis(nitrilomethylidyne)]bis[phenolate]](2-)N,N',O,O'-copper complex

419-610-7171866-24-3

STOT RE 2 *

Aquatic Chronic 2

H373**

H411

GHS08

GHS09

Wng

H373**

H411

030-009-00-5zinc-bis(4-(n-octyloxycarbonylamino)salicylate) dihydrate417-130-2—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

030-010-00-02-dodec-1-enylbutanedioic acid, 4-methyl ester zinc salt430-740-3—Aquatic Chronic 2H411GHS09H411
030-012-00-1aluminium-magnesium-zinc-carbonate-hydroxide423-570-6169314-88-9Aquatic Chronic 3H412—H412
030-015-00-8tetrazinc(2+)bis(hexacyanocobalt(3+))diacetate440-060-9—Aquatic Chronic 2H411GHS09H411
040-003-00-4reaction product of 3,5-di-tert-butylsalicylic acid and zirconium oxychloride, dehydrated, basic Zr: DTBS= 1,0: 1,0 to 1,0: 1,5430-610-6226996-19-6

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
042-005-00-0

reaction mass of: mono- and di-glycerols of canola oil;

canola oil acid amide of branched 1,3-propanediamine,N-[3-(tridecyloxy)-propyl];

N,N-diorgano dithiocarbamate molybdenum complex

434-240-6—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

046-001-00-Xtetraammine palladium (II) hydrogen carbonate425-270-0134620-00-1

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H302

H373**

H318

H317

H410

047-002-00-8polyphosphoric acid, copper, sodium, magnesium, calcium, silver and zinc salt416-850-4—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
050-021-00-4dichlorodioctyl stannane222-583-23542-36-7

Acute Tox. 3 *

STOT RE 1

Aquatic Chronic 3

H331

H372**

H412

GHS06

GHS08

Dgr

H331

H372**

H412

050-022-00-X

dibutyltin dichloride;

(DBTC)

211-670-0683-18-1

Muta. 2

Repr. 1B

Acute Tox. 2 *

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 1

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H341

H360FD

H330

H301

H312

H372**

H314

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H341

H360FD

H330

H301

H312

H372**

H314

H410

Skin Corr. 1B; H314: C ≥ 5 %

Skin Irrit. 2; H315: 0,01 % ≤ C < 5 %

Eye Dam. 1; H318: 3 % ≤ C < 5 %

Eye Irrit. 2; H319: 0,01 % ≤ C < 3 %

M=10

050-023-00-5

reaction mass of: bis[(2-ethyl-1-oxohexyl)oxy]dioctyl stannane;

bis[((2-ethyl-1-oxohexyl)oxy)dioctylstannyl]oxide;

bis(1-phenyl-1,3-decanedionyl)dioctyl stannane;

((2-ethyl-1-oxohexyl)oxy)-(1-phenyl-1,3-decanedionyl)dioctyl stannane

422-920-5—

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373**

H400

H410

GHS08

GHS09

Wng

H373**

H410

M=10
050-024-00-0

reaction mass of: tri-p-tolyltin hydroxide;

hexa-p-tolyl-distannoxane

432-230-6—

STOT RE 1

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H372**

H302

H315

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H372**

H302

H315

H318

H317

H410

064-001-00-8gadolinium(III)sulfite trihydrate456-900-251285-81-5Aquatic Chronic 2H411GHS09H411
078-010-00-Xtetraammine platinum (II) hydrogen carbonate426-730-3123439-82-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

078-011-00-5hydroxydisulfito platinum(II) acid423-310-161420-92-6

Acute Tox. 4 *

STOT RE 2 *

Skin Corr. 1A

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H373

H314

H334

H317

H412

GHS05

GHS08

GHS07

Dgr

H302

H373

H314

H334

H317

H412

078-012-00-0platinum(IV) nitrate/nitric acid solution432-400-1—

Skin Corr. 1A

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

082-012-00-6barium calcium cesium lead samarium strontium bromide chloride fluoride iodide europium doped431-780-4199876-46-5

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H302

H373**

H411

GHS08

GHS07

GHS09

Wng

H302

H373**

H411

601-070-00-0

reaction mass of: branched icosane;

branched docosane;

branched tetracosane

417-050-8151006-58-5

Acute Tox. 4 *

Aquatic Chronic 4

H332

H413

GHS07

Wng

H332

H413

601-072-00-1

reaction mass of: 1-(4-isopropylphenyl)-1-phenylethane;

1-(3-isopropylphenyl)-1-phenylethane;

1-(2-isopropylphenyl)-1-phenylethane

430-690-252783-21-8

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

601-075-00-84,4'-bis(N-carbamoyl-4-methylbenzenesulfonamide)diphenylmethane418-770-5151882-81-4Carc. 2H351

GHS08

Wng

H351
601-076-00-3ethynyl cyclopropane425-430-16746-94-7

Flam. Liq. 2

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H225

H315

H318

H412

GHS02

GHS05

Dgr

H225

H315

H318

H412

601-077-00-9

reaction mass of: 1-heptyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane;

1-nonyl-4-ethyl-2,6,7-trioxabicyclo[2.2.2]octane

426-510-7196965-91-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
601-078-00-4

reaction mass of: 1,7-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane;

2,3-dimethyl-2-[(3-methylbicyclo[2.2.1]hept-2-yl)methyl]bicyclo[2.2.1]heptane

427-040-5—

Skin Corr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H314

H400

H410

GHS05

GHS09

Dgr

H314

H410

601-079-00-X

reaction mass of: trans-trans-cyclohexadeca-1,9-diene;

cis-trans-cyclohexadeca-1,9-diene

429-620-3—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

601-080-00-5

reaction mass of: sec-butylphenyl(phenyl)methane, mixed isomers;

1-(sec-butylphenyl(phenyl)-2-phenylethane, mixed isomers;

1-(sec-butylphenyl-1-phenylethane, mixed isomers

431-100-6—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
601-081-00-0cyclohexadeca-1,9-diene431-730-14277-06-9

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

601-082-00-6

reaction mass of: endo-2-methyl-exo-3-methyl-exo-2-[(exo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane;

exo-2-methyl-exo-3-methyl-endo-2-[(endo-3-methylbicyclo[2.2.1]hept-exo-2-yl)methyl]bicyclo[2.2.1]heptane

434-420-4—

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

601-083-00-15-endo-hexyl-bicyclo[2.2.1]hept-2-ene435-000-322094-83-3

Asp. Tox. 1

Skin Irrit. 2

Aquatic Chronic 4

H304

H315

H413

GHS08

GHS07

Dgr

H304

H315

H413

601-084-00-7

reaction mass of: 5-endo-butyl-bicyclo[2.2.1]hept-2-ene;

5-exo-butyl-bicyclo[2.2.1]hept-2-ene (80:20)

435-180-3—

Asp. Tox. 1

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H304

H315

H400

H410

GHS08

GHS07

GHS09

Dgr

H304

H315

H410

602-095-00-X

alkanes, C14-17, chloro;

chlorinated paraffins, C14-17

287-477-085535-85-9

Lact.

Aquatic Acute 1

Aquatic Chronic 1

H362

H400

H410

GHS09

Wng

H362

H410

EUH066
602-098-00-62-(3-bromophenoxy)tetrahydro-2H-pyran429-030-657999-49-2

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

602-099-00-13-(4-fluorophenyl)-2-methylpropionylchloride426-370-7—

Skin Corr. 1A

Acute Tox. 4 *

Aquatic Chronic 3

H314

H302

H412

GHS05

GHS07

Dgr

H314

H302

H412

EUH014

EUH029

602-100-00-5

reaction mass of: (R,R)-1,1,1,2,2,3,4,5,5,5-decafluoropentane;

(S,S)-1,1,1,2,2,3,4,5,5,5-decafluoropentane

420-640-8—Aquatic Chronic 3H412—H412
602-101-00-02-chloro-4-fluoro-5-nitrophenyl (isobutyl)carbonate427-020-6141772-37-4

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373**

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H373**

H317

H410

602-102-00-61,1,1,3,3-pentafluorobutane430-250-1406-58-6Flam. Liq. 2H225

GHS02

Dgr

H225
602-103-00-11-(chlorophenylmethyl)-2-methylbenzene431-450-141870-52-4

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

602-104-00-71,1,2,2,3,3,4-heptafluorocyclopentane430-710-115290-77-4Aquatic Chronic 3H412—H412
602-105-00-2sodium 1,1,2,2,3,3,4,4,4-nonafluoro-1-butanesulfinate422-100-7102061-82-5

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

602-106-00-82-bromo-4,6-difluoroaniline429-430-0444-14-4

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

602-107-00-33,3,4,4-tetrafluoro-4-iodo-1-butene439-500-233831-83-3

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Chronic 2

H302

H315

H411

GHS07

GHS09

Wng

H302

H315

H411

602-108-00-9(2,3,5,6-tetrafluorophenyl)methanol443-840-74084-38-2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H302

H319

H317

GHS07

Wng

H302

H319

H317

603-109-00-7

reaction mass of: 1-ethoxy-1,1,2,3,3,3-hexafluoro-2-(trifluoromethyl)propane;

1-ethoxy-1,1,2,2,3,3,4,4,4-nonafluorobutane

425-340-0—Aquatic Chronic 4H413—H413
603-110-00-2

reaction mass of: cis-2-isobutyl-5-methyl 1,3-dioxane;

trans-2-isobutyl-5-methyl 1,3-dioxane

426-130-1166301-21-9

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

603-111-00-8

reaction mass of: 1-(1,1-dimethylpropyl)-4-ethoxy-cis-cyclohexane;

1-(1,1-dimethylpropyl)-4-ethoxy-trans-cyclohexane

426-530-6—

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

603-112-00-3cyclopentyl 2-phenylethyl ether428-340-9—

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

603-113-00-96-glycidyloxynapht-1-yl oxymethyloxirane429-960-227610-48-6

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H341

H312

H315

H317

H412

GHS08

GHS07

Wng

H341

H312

H315

H317

H412

603-114-00-49-(2-propenyloxy)tricyclo[5.2.1.0(2,6)]dec-3(or-4-)-ene430-830-226912-64-1

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

603-115-00-Xreaction mass of: O,O',O''-(methylsilanetriyl)tris(4-methyl-2-pentanone oxime) (3 stereoisomers)423-580-0—

STOT RE 2 *

Aquatic Chronic 4

H373**

H413

GHS08

Wng

H373**

H413

603-116-00-5(Z)-(2,4-difluorophenyl)piperidin-4-ylmethanone oxime monohydrochloride424-740-2138271-16-6

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

603-182-00-5reaction product of: saturated, monounsaturated and multiple unsaturated long-chained partly estrified alcohols of vegetable origin (Brassica napus L., Brassica rapa L., Helianthus annuus L., Glycine hispida, Gossypium hirsutum L., Cocos nucifera L., Elaeis guineensis) with O,O-diisobutyldithiophosphate and 2-ethylhexylamine and hydrogen peroxide428-630-5—Skin Sens. 1H317

GHS07

Wng

H317
603-188-00-8

reaction mass of: 6,7-epoxy-1,2,3,4,5,6,7,8-octahydro-1,1,2,4,4,7-hexamethylnaphthalene;

7,8-epoxy-1,2,3,4,6,7,8,8a-octahydro-1,1,2,4,4,7-hexamethylnaphthalene

426-970-9—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
603-190-00-98,8-dimethyl-7-isopropyl-6,10-dioxaspiro[4.5]decane424-030-262406-73-9

Skin Irrit. 2

Aquatic Chronic 3

H315

H412

GHS07

Wng

H315

H412

603-192-00-X(E,E)-3,7,11-trimethyldodeca-1,4,6,10-tetraen-3-ol423-240-1125474-34-2

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

603-193-00-5disodium 9,10-anthracenedioxide426-030-846492-07-3Skin Corr. 1AH314

GHS05

Dgr

H314
603-194-00-0

2-(2-aminoethylamino)ethanol;

(AEEA)

203-867-5111-41-1

Repr. 1B

Skin Corr. 1B

Skin Sens. 1

H360Fd

H361

H314

H317

GHS05

GHS08

GHS07

Dgr

H360Fd

H361

H314

H317

STOT SE 3; H335: C ≥ 5 %
603-200-00-1

1-pentanol; [1]

3-pentanol [2]

200-752-1 [1]

209-526-7 [2]

71-41-0 [1]

584-02-1 [2]

Flam. Liq. 3

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

H226

H332

H335

H315

GHS02

GHS07

Wng

H226

H332

H335

H315

603-201-00-7(E)-(7R, 11R)-3,7,11,15-tetramethylhexadec-2-ene-1-ol416-120-5—

Skin Irrit. 2

Aquatic Chronic 4

H315

H413

GHS07

Wng

H315

H413

603-202-00-24,4,5,5,5-pentafluoropentan-1-ol421-360-9148043-73-6

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

603-203-00-8(1R,3S,7R,8R,10R,13R)-5,5,7,9,9,13-hexamethyl-4,6-dioxatetracyclo[6.5.1.01,10.03,7]tetradecane427-580-1—Skin Irrit. 2H315

GHS07

Wng

H315
603-204-00-3

reaction mass of: 2,2'-(heptane-1,7-diyl)bis-1,3-dioxolane;

2,2'-(heptane-1,6-diyl)bis-1,3-dioxolane

428-110-8—Aquatic Chronic 3H412—H412
603-205-00-9(1S-cis)-4-(2-amino-6-chloro-9H-purin-9-yl)-2-cyclopentene-1-methanol hydrochloride426-200-1172015-79-1

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H372**

H302

H318

H317

H412

GHS05

GHS08

GHS07

Dgr

H372**

H302

H318

H317

H412

603-206-00-42,2-dichloro-1,3-benzodioxol426-850-62032-75-9

Flam. Liq. 3

Skin Corr. 1A

Acute Tox. 4 *

Skin Sens. 1

H226

H314

H302

H317

GHS02

GHS05

GHS07

Dgr

H226

H314

H302

H317

EUH014
603-207-00-X2-isobutyl-2-isopropyl-1,3-dimethoxypropane430-800-9129228-21-3

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

603-208-00-51,2-diethoxyethane211-076-1629-14-1

Flam. Liq. 2

Repr. 1A

Eye Irrit. 2

H225

H360Df

H319

GHS02

GHS08

GHS07

Dgr

H225

H360Df

H319

EUH019
603-209-00-0

spinosad (ISO) (reaction mass of spinosyn A and spinosyn D in ratios between 95:5 to 50:50);

reaction mass of 50-95 % of (2R, 3aS, 5aR, 5bS, 9S, 13S, 14R, 16aS, 16bR)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-14-methyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione and 50-5 % (2S, 3aR, 5aS, 5bS, 9S, 13S, 14R, 16aS, 16bS)-2-(6-deoxy-2,3,4-tri-O-methyl-α-l-mannopyranosyloxy)-13-(4-dimethylamino-2,3,4,6-tetradeoxy-β-d-erythropyranosyloxy)-9-ethyl-2,3,3a,5a,5b,6,7,9,10,11,12,13,14,15,16a,16b-hexadecahydro-4,14-dimethyl-1H-8-oxacyclododeca[b]as-indacene-7,15-dione; [1]

spinosyn A; [2]

spinosyn D [3]

- [1]

- [2]

- [3]

- [1]

131929-60-7 [2]

131929-63-0 [3]

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410M=10
603-210-00-62,4-diethyl-1,5-pentanediol429-310-857987-55-0Eye Dam. 1H318

GHS05

Dgr

H318
603-211-00-1

2,3-epoxypropyltrimethylammonium chloride … %;

glycidyl trimethylammonium chloride … %

221-221-03033-77-0

Carc. 1B

Muta. 2

Repr. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H350

H341

H361f***

H312

H302

H373**

H318

H317

H412

GHS05

GHS08

GHS07

Dgr

H350

H341

H361f***

H312

H302

H373**

H318

H317

H412

B
603-212-00-7

1,3,4,6,7,8-hexahydro-4,6,6,7,8,8-hexamethylindeno[5,6-c]pyran;

galaxolide;

(HHCB)

214-946-91222-05-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
603-213-00-2

2-methoxy-2-methylbutane;

tert-amyl methyl ether

213-611-4994-05-8

Flam. Liq. 2

Acute Tox. 4 *

STOT SE 3

H225

H302

H336

GHS02

GHS07

Dgr

H225

H302

H336

603-214-00-81,1-diisopropoxycyclohexane413-740-81132-95-2Skin Corr. 1BH314

GHS05

Dgr

H314
603-215-00-31-hydroxy-4-fluoro-1,4-diazoniabicyclo[2.2.2]octane bis(tetrafluoroborate)418-330-2162241-33-0

Expl. 1.1****

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H201

H302

H373**

H318

H317

H400

H410

GHS01

GHS05

GHS08

GHS07

GHS09

Dgr

H201

H302

H373**

H318

H317

H410

603-216-00-9 cis-1-amino-2,3-dihydro-1H-inden-2-ol422-660-27480-35-5

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

603-217-00-42,4,6-tri-tert-butylphenyl 2-butyl-2-ethyl-1,3-propanediolphosphite423-560-1161717-32-4

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

603-220-00-01-{]benzyl[}2-(2-methoxyphenoxy)ethyl{]amino[}-3-(9H-carbazol-4-yloxy)propan-2-ol432-890-572955-94-3Aquatic Chronic 4H413—H413
603-221-00-6

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing < 0,1 % 4-chloroaniline (EC No 203-401-0)]

433-580-2214353-17-0

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H302

H314

H411

GHS05

GHS07

GHS09

Dgr

H302

H314

H411

603-221-01-3

1-(2-amino-5-chlorophenyl)-2,2,2-trifluoro-1,1-ethanediol, hydrochloride;

[containing ≥ 0,1 % 4-chloroaniline (EC No 203-401-0)]

433-580-2214353-17-0

Carc. 1B

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 2

H350

H302

H314

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H350

H302

H314

H411

603-222-00-1(2R, 3S, 4R, 5R, 7R, 9R, 10R, 11S, 12S, 13R)-10-[(4-dimethylamino-3-hydroxy-6-methyltetrahydropyran-2-yl)oxy]-2-ethyl-3,4,12-trihydroxy-9-methoxy-3,5,7,9,11,13-hexamethyl-6,14-dioxo-1-oxacyclotetradecane433-820-6118058-74-5Eye Irrit. 2H319

GHS07

Wng

H319
603-223-00-7

2-cyclopentylidene cyclopentanol;

1,1'-bi(cyclopentyliden)-2-ol

434-270-16261-30-9

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H315

H318

H412

GHS05

Dgr

H315

H318

H412

603-224-00-23-ethoxy-1,1,1,2,3,4,4,5,5,6,6,6-dodecafluoro-2-(trifluoromethyl)-hexane435-790-1297730-93-9Aquatic Chronic 4H413—H413
603-225-00-8

erythromycin A9-oxime (E);

(3R, 4S, 5S, 6R, 7R, 9R, 11R, 12R, 13S, 14R)-4-((2,6-didesoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopiranosyl)oxy)-14-ethyl-7,12,13-trihydroxy-3,5,7,9,11,13-hexamethyl-6-((3,4,6-tridesoxy-3-dimethylamino-β-d-xylohexapiranosyl)oxy)oxacyclotetradecan-2-ona-10-oxime (E)

437-070-013127-18-9Aquatic Chronic 2H411GHS09H411
603-226-00-34,4'(4-(4-methoxyphenyl)-1,3,5-triazin-2,4-diyl)bisbenzene-1,3-diol444-500-01440-00-2Aquatic Chronic 3H412—H412
603-227-00-9

α-hydro-ω-[[[(1,1-dimethylethyl)dioxy]carbonyl]oxy]-poly[oxy(methyl-1,2-ethanediyl)] ether with 2,2-bis(hydroxymethyl)-1,3-propanediol (4:1);

reaction product of: α-hydro-ω-((chlorocarbonyl)oxy)-poly(oxy(methyl-1,2-ethanediyl)) ether with 2,2-bis(hydroxymethyl)-1,3-propanediol with potassium 1,1-dimethylethylperoxalate

445-060-2203574-04-3

****

Aquatic Acute 1

Aquatic Chronic 1

****

H400

H410

****

GHS09

Wng

****

H410

603-228-00-4

(+/–)-(R*, R*)-6-fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran;

6-fluoro-2-(2-oxiranyl)chromane

419-620-1—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

603-229-00-Xsodium (Z)-3-chloro-3-(4-chlorophenyl)-1-hydroxy-2-propene-1-sulfonate420-800-7—

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

603-230-00-52,6,6,7,8,8-hexamethyldecahydro-2H-indeno[4,5-b]furan440-030-5—

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 4

H315

H318

H413

GHS05

Dgr

H315

H318

H413

603-231-00-0(S)-1,1-diphenyl-1,2-propanediol443-220-6—Aquatic Chronic 3H412—H412
603-232-00-63,3,8,8,10,10-hexamethyl-9-[1-(4-oxiranylmethoxy-phenyl)-ethoxy]-1,5-dioxa-9-aza-spiro[5.5]undecane444-420-6—Aquatic Chronic 4H413—H413
603-233-00-1

reaction mass of: 4-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

4-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)-3-methylbutan-2-ol;

1-(1,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

1-(3,3a,4,6,7,7a-hexahydro-4,7-methanoinden-5-ylidene)pentan-3-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-1H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol;

(E)-4-(3a,4,5,6,7,7a-hexahydro-3H-4,7-methanoinden-5-yl)-3-methylbut-3-en-2-ol

444-430-0—Aquatic Chronic 2H411GHS09H411
603-234-00-7(1R, 4R)-4-methoxy-2,2,7,7-tetramethyltricyclo(6.2.1.0(1,6))undec-5-ene444-480-3—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

604-071-00-44,4'-(1-{]4-[}1-(4-hydroxyphenyl)-1-methylethyl{]phenyl[}ethylidene)diphenol425-600-3110726-28-8Aquatic Chronic 4H413—H413
604-072-00-X1,2-bis(phenoxymethyl)benzene428-620-010403-74-4

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
604-073-00-5(E)-3-[1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-phenylbut-1-enyl]phenol428-010-482413-20-5

Carc. 2

Repr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H360F***

H317

H400

H410

GHS08

GHS07

GHS09

Dgr

H351

H360F***

H317

H410

604-074-00-0

tetrabromobisphenol-A;

2,2', 6,6'-tetrabromo-4,4'-isopropylidenediphenol

201-236-979-94-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
604-075-00-6

4-(1,1,3,3-tetramethylbutyl)phenol;

4-tert-octylphenol

205-426-2140-66-9

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H400

H410

GHS05

GHS09

Dgr

H315

H318

H410

M=10
604-076-00-1phenolphthalein201-004-777-09-8

Carc. 1B

Muta. 2

Repr. 2

H350

H341

H361f***

GHS08

Dgr

H350

H341

H361f***

Carc. 1A; H350: C ≥ 1 %
604-077-00-72-benzotriazol-2-yl-4-methyl-6-(2-methylallyl)phenol419-750-998809-58-6Aquatic Chronic 4H413—H413
604-079-00-84,4'-(1,3-phenylene-bis(1-methylethylidene))bis-phenol428-970-413595-25-0

Repr. 2

Skin Sens. 1

Aquatic Chronic 2

H361f***

H317

H411

GHS08

GHS09

Wng

H361f***

H317

H411

604-080-00-34-fluoro-3-trifluoromethylphenol432-560-061721-07-1

Acute Tox. 4 *

Skin Corr. 1A

Skin Sens. 1

Aquatic Chronic 2

H332

H314

H317

H411

GHS05

GHS07

GHS09

Dgr

H332

H314

H317

H411

604-081-00-91,1-bis(4-hydroxyphenyl)-1-phenylethane433-130-51571-75-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
604-082-00-42-chloro-6-fluoro-phenol433-890-82040-90-6

Muta. 1B

Repr. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H340

H361f***

H302

H314

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H340

H361f***

H302

H314

H317

H411

604-083-00-X4,4'-sulfonylbisphenol, polymer with ammonium chloride(NH4Cl), pentachlorophosphorane and phenol439-270-3260408-02-4Aquatic Chronic 4H413—H413
604-084-00-51-ethoxy-2,3-difluorobenzene441-000-4121219-07-6

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

604-087-00-1

reaction mass of: 1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)monoester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)diester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol;

1,2-naphthoquinonediazide-5-sulfonylchloride (or sulfonic acid)triester with 4,4'-(1-(4-(1-(4-hydroxyphenyl)-1-methylethyl)phenyl)ethylidene)bisphenol

433-640-8—

Pyr. Sol. 1

Aquatic Chronic 4

H250

H413

GHS02

Dgr

H250

H413

EUH044
604-089-00-22-methyl-5-tert-butylthiophenol444-970-7—

Flam. Liq. 3

Repr. 2

STOT RE 2 *

Asp. Tox. 1

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

STOT SE 3

Aquatic Acute 1

Aquatic Chronic 1

H226

H361d***

H373**

H304

H319

H315

H317

H336

H400

H410

GHS02

GHS08

GHS07

GHS09

Dgr

H226

H361d***

H373**

H304

H319

H315

H317

H336

H410

605-023-00-55-chloro-2-(4-chlorophenoxy)phenol429-290-03380-30-1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

605-024-00-02-bromo-5-hydroxy-4-methoxybenzaldehyde426-540-02973-59-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

605-032-00-43-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-(E)-2-propenal425-370-493957-50-7

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

605-033-00-X

reaction mass of: 3,7,11-trimethyl-cis-6,10-dodecadienal;

3,7,11-trimethyl-trans-6,10-dodecadienal

425-910-932480-08-3

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H315

H400

H410

GHS07

GHS09

Wng

H315

H410

605-034-00-5

reaction mass of: (1RS, 2RS, 3SR, 6RS, 9SR)-9-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;

(1RS, 2RS, 3RS, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-3-carbaldehyde;

(1RS, 2RS, 4SR, 6RS, 8SR)-8-methoxytricyclo[5.2.1.0(2,6)]decane-4-carbaldehyde

429-860-9—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

605-035-00-0(E)-3-(4-(4-fluorophenyl)-5-methoxymethyl-2,6-bis(1-methoxymethyl)pyridin-3-yl)prop-2-enal426-330-9177964-68-0

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H319

H317

H413

GHS07

Wng

H319

H317

H413

605-036-00-62-bromomalonaldehyde430-470-62065-75-0

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

605-037-00-1

trans-3-[2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde;

3-[(E)-2-(7-chloro-2-quinolinyl)vinyl]benzaldehyde

421-800-1120578-03-2Aquatic Chronic 4H413—H413
605-038-00-73-methyl-5-phenylpentan-1-al433-900-055066-49-4

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H302

H315

H317

H411

GHS07

GHS09

Wng

H302

H315

H317

H411

605-039-00-23,4-dihydroxy-5-nitrobenzaldehyde441-810-8116313-85-0

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H302

H318

H317

GHS05

GHS07

Dgr

H302

H318

H317

606-074-00-6

reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene;

(2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene

425-570-1—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
606-090-00-31-[3-[(dimethylamino)methyl]-4-hydroxyphenyl]ethanone430-920-173096-98-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

606-093-00-X5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one414-470-395885-13-5

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

606-094-00-5 N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1'(3'H)-isobenzofuran]-3'-one417-460-7—Aquatic Chronic 4H413—H413
606-095-00-0(R,S)-2-azabicyclo[2.2.1]hept-5-en-3-one421-830-349805-30-3

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

606-096-00-63-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one424-170-4130603-71-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

606-097-00-12,2''-dihydroxy-4,4''-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone424-210-023911-85-5Aquatic Chronic 4H413—H413
606-098-00-71-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione431-220-9158574-65-3Aquatic Chronic 4H413—H413
606-099-00-25-methoxy-4'-(trifluoromethyl)valerophenone425-000-161718-80-7Aquatic Chronic 2H411GHS09H411
606-100-00-62-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one425-150-894723-86-1

Repr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H360F***

H302

H317

H412

GHS08

GHS07

Dgr

H360F***

H302

H317

H412

606-101-00-1

reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione;

1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;

1,5-bis[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione;

1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione;

1-[3-[(2-ethylhexyl)oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione;

1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione

426-050-7165038-51-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
606-102-00-74-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone431-490-879876-59-8Aquatic Chronic 2H411GHS09H411
606-103-00-21-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone426-460-6—Skin Sens. 1H317

GHS07

Wng

H317
606-104-00-81-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone426-830-778531-59-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-105-00-33,4,3', 4'-tetraphenyl-1,1'-ethandiylbispyrol-2,5-dione431-500-0226065-73-2

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-106-00-91-(4-(trans-4-butylcyclohexyl)phenyl)ethanone427-320-783626-30-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-107-00-48-azaspiro[4.5]decane-7,9-dione427-770-41075-89-4

Acute Tox. 3 *

Aquatic Chronic 2

H301

H411

GHS06

GHS09

Dgr

H301

H411

606-108-00-X1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone436-710-6756-13-8Aquatic Chronic 3H412—H412
606-109-00-52-(4-methyl-3-pentenyl)anthraquinone428-320-171308-16-2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 4

H302

H317

H314

GHS07

Wng

H302

H317

H314

606-110-00-05-ethoxy-5H-furan-2-one428-330-42833-30-9

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

H314

H312

H302

H373**

H317

GHS05

GHS08

GHS07

Dgr

H314

H312

H302

H373**

H317

606-111-00-65-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one428-410-967014-36-2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

606-112-00-1(4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one428-690-21668-86-6

Acute Tox. 4 *

Eye Irrit. 2

Aquatic Chronic 3

H302

H319

H412

GHS07

Wng

H302

H319

H412

606-113-00-71-[4-(4-benzoylphenylsulfanyl)phenyl]-2-methyl-2-(4-methylphenylsulfonyl)propan-1-one429-040-0272460-97-6

Eye Dam. 1

Aquatic Chronic 4

H318

H314

GHS05

Dgr

H318

H314

606-114-00-24,4', 5,5', 6,6', 7,7'-octachloro-(2,2')biisoindolyl-1,1', 3,3'-tetraone429-150-967887-47-2Aquatic Chronic 4H413—H413
606-115-00-8

profoxydim (ISO);

2-{](EZ)-1-[}(2RS)-2-(4-chlorophenoxy)propoxyimino{]butyl[}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one

—139001-49-3

Carc. 2

Repr. 2

Skin Sens. 1

H351

H361d

H317

GHS08

GHS07

Wng

H351

H361d

H317

606-116-00-3

tepraloxydim (ISO);

(RS)-(EZ)-2-{]1-[}(2E)-3-chloroallyloxyimino{]propyl[}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one

—149979-41-9

Carc. 2

Repr. 2

H351

H361fd

GHS08

Wng

H351

H361fd

606-117-00-92,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one429-460-47078-98-0

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-118-00-4 N-(1,3-dimethylbutyl)-N'-(phenyl)-1,4-benzoquinonediimine429-640-252870-46-9

Eye Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H400

H410

GHS07

GHS09

Wng

H319

H410

606-119-00-X(E)-3-methyl-5-cyclopentadecen-1-one429-900-5—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

606-120-00-52,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one430-170-5114625-74-0

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

606-121-00-0(+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1'-(cyclohex-2'-en-4'-one)430-460-1133636-82-5

Skin Corr. 1B

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

606-122-00-63-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one430-820-8114341-88-7

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H315

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H302

H373**

H315

H318

H317

H410

606-123-00-14-hexadecyl-1-phenylpyrazolidin-3-one430-840-7—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

606-124-00-71-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione421-080-7161462-35-7

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373**

H400

H410

GHS08

GHS09

Wng

H373**

H410

606-125-00-21-benzylimidazolidine-2,4-dione421-340-16777-05-5Acute Tox. 4 *H302

GHS07

Wng

H302
606-126-00-81,4-bis(2,3-dihydroxypropylamino)anthraquinone421-470-799788-75-7Aquatic Chronic 2H411GHS09H411
606-128-00-92,2'-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione422-650-8148935-94-8Aquatic Chronic 4H413—H413
606-129-00-4

5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one;

(2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one

423-090-7156732-13-7Aquatic Chronic 4H413—H413
606-130-00-X4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone423-860-256309-94-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

606-131-00-5cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione427-230-85571-36-8

Repr. 1B

STOT RE 2 *

Aquatic Chronic 2

H360F***

H373**

H411

GHS08

GHS09

Dgr

H360F***

H373**

H411

606-132-00-0(6β)-6,19-epoxyandrost-4-ene-3,17-dione433-490-36563-83-3

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

606-134-00-1androsta-1,4,9(11)-triene-3,17-dione433-560-315375-21-0Repr. 2H361f***

GHS08

Wng

H361f***
606-135-00-7cyclohexadecanone438-930-82550-52-9Aquatic Chronic 4H413—H413
606-136-00-2(3S, 6R, 9S, 12R, 15S, 18R, 21S, 24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone444-350-6133413-70-4

Eye Irrit. 2

Aquatic Chronic 4

H319

H413

GHS07

Wng

H319

H413

606-137-00-8 trans-7,7'-dimethyl-(4H, 4H')-(2,2')bi[benzo[1,4]thiazinylidene]-3,3'-dione444-750-0211387-26-7Aquatic Chronic 4H413—H413
606-138-00-3(2-butyl-5-nitrobenzofuran-3-yl)[4-(3-dibutylaminopropoxy)phenyl]methanone444-800-1141645-23-0

Flam. Liq. 3

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H226

H302

H373**

H315

H318

H317

H400

H410

GHS02

GHS05

GHS08

GHS07

GHS09

Dgr

H226

H302

H373**

H315

H318

H317

H410

M=10
606-139-00-9(S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one444-830-5124379-29-9Aquatic Chronic 4H413—H413
606-140-00-42-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one444-860-9474510-57-1

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373**

H400

H410

GHS08

GHS09

Wng

H373**

H410

606-141-00-Xsodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate418-410-7—Eye Irrit. 2H319

GHS07

Wng

H319
606-142-00-5

reaction mass of: (1RS, 2SR, 7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one;

(1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one

434-290-9—

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-417-00-23-chloropropyl chloroformiate425-770-9628-11-5

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H331

H302

H373**

H315

H318

H317

GHS06

GHS05

GHS08

Dgr

H331

H302

H373**

H315

H318

H317

607-428-00-2tetrasodium ethylene diamine tetraacetate200-573-964-02-8

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

607-429-00-8

edetic acid;

(EDTA)

200-449-460-00-4Eye Irrit. 2H319

GHS07

Wng

H319
607-471-00-71,6-bis((dibenzylthiocarbamoyl)disulfanyl)hexane429-280-6151900-44-6Aquatic Chronic 4H413—H413
607-473-00-8pentaerythritol, dipentaerythritol, fatty acids, C6-10, mixed esters with adipic acid, heptanoic acid and isostearic acid426-590-3187412-41-5Skin Sens. 1H317

GHS07

Wng

H317
607-477-00-X(1α5α6α)-6-nitro-3-benzyl-3-azabicyclo[3.1.0]hexane methanesulfonate salt426-740-8—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

607-481-00-1

reaction mass of: trihexyl citrate;

dihexyloctyl citrate;

dioctylhexyl citrate;

dihexyldecyl citrate

430-290-8—Aquatic Chronic 4H413—H413
607-482-00-7 N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-l-alanyl-N-carboxyanhydride430-360-884793-24-8

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-483-00-2

1,2-benzenedicarboxylic acid;

di-C6-8-branched alkylesters, C7-rich

276-158-171888-89-6Repr. 1BH360D***

GHS08

Dgr

H360D***
607-484-00-8ethyl 2-{][}3-acetylamino-4-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)phenyl{]ethylamino[}propionate430-480-0221452-67-1Aquatic Chronic 4H413—H413
607-485-00-3(3S-trans)-phenyl-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-piperidinecarboxylate430-510-2—Aquatic Chronic 4H413—H413
607-486-00-9potassium sodium 5'-(6-chloro-4-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino)-4'-hydroxy-2,3'-azodinaphthalene-1,2', 5,7'-disulfonate402-110-8110081-40-8Aquatic Chronic 3H412—H412
607-491-00-6

reaction mass of: diester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:2);

triester of 4,4'-methylenebis[2-(2-hydroxy-5-methylbenzyl)-3,6-dimethylphenol] and 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulfonic acid (1:3)

427-140-9—Carc. 2H351

GHS08

Wng

H351
607-504-00-5diammonium 1-hydroxy-2-(4-(4-carboxyphenylazo)-2,5-dimethoxyphenylazo)-7-amino-3-naphthalenesulfonate422-670-7—

Repr. 1A

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H361f

H301

H373**

H400

H410

GHS06

GHS08

GHS09

Dgr

H361f

H301

H373**

H410

607-509-00-22-phenoxyethyl 4-aminobenzoate430-880-588938-23-2Aquatic Chronic 2H411GHS09H411
607-510-00-8(2S, 5R)-6,6-dibromo-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide427-200-476646-91-8

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

H302

H315

H318

H317

GHS05

GHS07

Dgr

H302

H315

H318

H317

607-511-00-3

reaction mass of: 4-[(3-decyloxypropyl)(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)amino]-4-oxobutyric acid;

4-[(3-isobutoxy-1-isobutoxycarbonyl-3-oxopropyl)(3-octyloxypropyl)amino]-4-oxobutyric acid

423-750-4—

Eye Irrit. 2

Aquatic Chronic 2

H319

H411

GHS07

GHS09

Wng

H319

H411

607-514-00-Xpotassium N-(1-methoxy-1-oxobut-2-en-3-yl)valinate427-240-2134841-35-3Skin Sens. 1H317

GHS07

Wng

H317
607-518-00-13-oxoandrost-4-ene-17-β-carboxylic acid414-990-0302-97-6

Repr. 1A

Aquatic Chronic 4

H361f

H413

GHS08

Dgr

H361f

H413

607-519-00-7poly-[((4-((4-ethyl-ethylene)amino)phenyl)-((4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)cyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]427-280-0176429-27-9

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H335

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H335

H315

H318

H410

607-520-00-2

reaction mass of: sodium 4,5-dihydro-2-[(propionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate;

disodium 4,5-dihydro-2-[(dipropionato)(C6-18)alkyl]-3H-imidazolium-N-ethylphosphate

427-740-0—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-521-00-8tetraethyl N,N'-(methylenedicyclohexane-4,1-diyl)bis-dl-aspartate429-270-1136210-30-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-522-00-3sodium salt of the polymer of: sodium 2-methyl-buta-1,3-diene-1-sulfonate with acrylic acid and 2-hydroxyethyl-2-methylacrylate429-720-7184246-86-4Aquatic Chronic 3H412—H412
607-523-00-9reaction mass of mono to tetra(lithium and/or sodium)3-amino-10-[4-(4-amino-3-sulfonatoanilino)-6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to tetra(lithium and/or sodium)3-amino-10-[4,6-bis(4-amino-3-sulfonatoanilino)-1,3,5-triazin-2-ylamino]-6-13-dichlorobenzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to penta(lithium and/or sodium)10,10'-diamino-6,6', 13,13'-tetrachloro-3,3'-[6-[methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10-amino-6,6', 13,13'-tetrachloro-10'[4-(4-amino-3-sulfonatoanilino)-[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate; mono to hepta(lithium and/or sodium)10,10'-diamino-6,6', 3,3'[(2-sulfonato)-1,4-phenylenediiminobis[6-methyl-(2-sulfonatoethyl)amino]-1,3,5-triazin-2,4-diyldiimino]bis[benzo[1,2-B:4,5-B']di[1,4]benzoxazine-4,11-disulfonate430-200-7—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-524-00-4tall oil 2-[(tetrahydro-2H-pyran-2-yl) thio]ethyl esters430-310-5—Aquatic Chronic 4H413H413
607-525-00-X(Z)-2-methoxymino-2-[2-(tritylamino)thiazol-4-yl]acetic acid431-520-164485-90-1

Flam. Sol. 1****

Carc. 2

Aquatic Chronic 3

H228

H351

H412

GHS02

GHS08

Dgr

H228

H351

H412

607-528-00-6(S)-3-methyl-2-(2-oxotetrahydropyrimidine-1-yl)butyric acid430-900-2192725-50-1Eye Dam. 1H318

GHS05

Dgr

H318
607-529-00-1benzyl cis-4-ammonium-4'-toluenesulfonato-1-cyclohexanecarboxylate426-070-667299-45-0Aquatic Chronic 3H412—H412
607-530-00-7reaction mass of isomers of: C7-9-alkyl 3-(3,5-di-tert-butyl-4-hydroxyphenyl)propionate406-040-9125643-61-0Aquatic Chronic 4H413—H413
607-531-00-2methyl 3-amino-4,6-dibromo-2-methyl-benzoate425-190-6119916-05-1

STOT RE 2 *

Aquatic Chronic 2

H373**

H411

GHS08

GHS09

Wng

H373**

H411

607-532-00-8(S)-1-[2-tert-butoxycarbonyl-3-(2-methoxyethoxy)propyl]-1-cyclopentanecarboxylic acid, cyclohexylamine salt425-510-4167944-94-7Aquatic Chronic 3H412—H412
607-533-00-3pentasodium monohydrogen 6-chloro-3,10-bis[2-[4-chloro-6-(2,4-disulfophenylamino)-1,3,5-triazin-2-yl-amino]ethylamino]-13-ethylbenzo[5.6][1.4]oxazino[2,3-b]phenoxazine-4,11-disulfonate414-910-4—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-534-00-9ethyl 2-(3-benzoylphenyl)propanoate414-920-960658-04-0

Acute Tox. 3 *

STOT RE 1

Skin Sens. 1

Aquatic Chronic 2

H301

H372**

H317

H411

GHS06

GHS08

GHS09

Dgr

H301

H372**

H317

H411

607-535-00-4potassium 4-iodo-2-sulfonato-benzoic acid426-620-5—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-536-00-X(2,6-xylyloxy) acetic acid430-910-713335-71-2

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

607-537-00-5isopropylammonium 2-(3-benzoylphenyl)propionate417-970-1—

Acute Tox. 3 *

Acute Tox. 4 *

STOT RE 1

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H312

H372**

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H301

H312

H372**

H318

H410

607-539-00-6propyl((4-(5-oxo-3-propylisoxazolidin-4-ylidenmethin)phenyl)propoxycarbonylmethyleneamino)acetate431-000-2198705-81-6Aquatic Chronic 4H413—H413
607-540-00-11-(mercaptomethyl)cyclopropylacetic acid420-240-3162515-68-6

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H314

H312

H302

H317

H411

GHS05

GHS07

GHS09

Dgr

H314

H312

H302

H317

H411

607-541-00-7[(1-methyl-1,2-ethanediyl)bis[nitrilobis(methylene)]]tetrakis(phosphonic acid)421-940-128698-31-9

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

607-542-00-2methyl 2-(4-butanesulfonamidophenoxy)tetradecanoate422-110-1—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
607-543-00-8poly-[((4-((4-(ethyl-ethylene)amino)phenyl)-(4-(ethyl-(2-oxyethylene)amino)phenyl)methinyl)-3-methylcyclohexa-2,5-dienylidene)-N-ethyl-N-(2-hydroxyethyl)ammonium acetate]427-480-8176429-22-4

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H335

H315

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H335

H315

H318

H410

607-544-00-3ethyl 6,8-difluoro-1-(formylmethylamino)-1,4-dihydro-7-(4-methyl)piperazin-1-yl)-4-oxo-quinoline-3-carboxylate427-490-2158585-86-5Aquatic Chronic 3H412—H412
607-545-00-91,2-dimethyl-3-(1-methylethenyl)cyclopentyl acetate424-070-094346-09-5

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-546-00-4

reaction mass of: methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]methoxycarbonylmethylamino[}acetate;

methyl {][}5-acetylamino-4-(2-chloro-4-nitrophenylazo)phenyl{]ethoxycarbonylmethylamino[}acetate

424-290-7188070-47-5Skin Sens. 1H317

GHS07

Wng

H317
607-547-00-X18-methylnonadecyl 2,2 -dimethylpropanoate424-370-1125496-22-2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic

H315

H317

H413

GHS07

Wng

H315

H317

H413

607-548-00-51-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone methanesulfonate431-010-7154486-26-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

607-549-00-0methyl (E)-2((3-(1,3-benzodioxol-5-yl)-2-methyl-1-propenyl)amino)benzoate424-430-7125778-19-0

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
607-550-00-62-amino-4-bromo-5-chlorobenzoic acid424-700-4—

Eye Dam. 1

Aquatic Chronic 3

H318

H410

GHS05

Dgr

H318

H410

607-551-00-1tetrabutylammonium 2-amino-6-iodopurinate424-710-9156126-48-6

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H312

H302

H373**

H315

H318

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H312

H302

H373**

H315

H318

H317

H411

607-552-00-7hexadecyl 3-amino-4-isopropoxybenzoate424-830-1—Aquatic Chronic 4H413—H413
607-553-00-27-amino-4-hydroxy-2-naphthalenesulfonic acid, coupled with 5 (or 8) -amino-8 (or 5)-[[4-[[4-[[4-amino-6(or 7)-sulfo-1-naphthyl]azo]phenyl]amino]-3-sulfophenyl]azo]-2-naphthalenesulfonic acid and 4-hydroxy-7-(phenylamino)-2-naphthalenesulfonic acid, sodium salt424-850-0—Eye Dam. 1H318

GHS05

Dgr

H318
607-554-00-82,4-diamino-5-[4-[(2-sulfoxyl ethyl)sulfonyl]phenylazo]benzenesulfonic acid424-870-127624-67-5

Expl. 1.1

Eye Dam. 1

Aquatic Chronic 3

H201

H318

H412

GHS01

GHS05

Dgr

H201

H318

H412

607-555-00-31,1,3,3-tetramethylbutylperoxypivalate424-980-822288-41-1

Flam. Liq. 2

Org. Perox. D

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H225

H242

H315

H317

H411

GHS02

GHS07

GHS09

Dgr

H225

H242

H315

H317

H411

607-556-00-92-acetoxymethylene-4-acetylphenylacetate425-160-224085-06-1

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H318

H317

H400

H410

GHS05 GHS08 GHS07 GHS09 Dgr

H302

H373**

H318

H317

H410

607-557-00-4salt of: (1S-cis)-1-amino-2,3-dihydro-1H-inden-2-ol and [R-[R*R*]]-2,3-dihydroxybutanedioic acid425-210-3169939-84-8Skin Sens. 1H317

GHS07

Wng

H317
607-558-00-X2S-isopropyl-5R-methyl-1R-cyclohexyl (2R, 5S)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-[1.3]-oxathiolane-2-carboxylate425-250-1147027-10-9Aquatic Chronic 2H411GHS09H411
607-559-00-5coconut oil, reaction products with glycerol esters of 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoic acid425-400-6179986-09-5Aquatic Chronic 4H413—H413
607-560-00-0(R,S)-2-butyloctanedioic acid431-210-450905-10-7Eye Dam. 1H318

GHS05

Dgr

H318
607-561-00-6sodium 4-hydroxy-3-(N'-(2-(2-hydroxyethylenesulfonyl)ethylene)ureido)-5-nitrobenzenesulfonate425-460-3—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-562-00-1

reaction mass of: (2R, 3R)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate;

(2S, 3S)-3-(2-ethoxyphenoxy)-2-hydroxy-3-phenylpropylammonium methanesulfonate

425-530-398769-75-6

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

607-563-00-75,7-dichloro-4-hydroxyquinoline-3-carboxylic acid431-250-2171850-30-9Aquatic Chronic 2H411GHS09H411
607-564-00-21,6-hexanediammonium, sodium 5-sulfato-1,3-benzenedicarboxylate425-730-051178-75-7Skin Sens. 1H317

GHS07

Wng

H317
607-565-00-83-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5-pyridinedicarboxylate425-820-188150-42-9

Acute Tox. 3 *

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H373**

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H301

H373**

H318

H410

607-566-00-3

reaction mass of: dodecylphenyl dodecylhydroxybenzenecarboxylate;

bis(dodecylphenyl)dodecyl hydroxybenzenedicarboxylate

426-140-6—Aquatic Chronic 4H413—H413
607-567-00-9potassium 3-iodo-6-methylbenzenesulfonate426-300-5—Eye Dam. 1H318

GHS05

Dgr

H318
607-568-00-4potassium 2-chloro-3-(benzyloxy)propionate426-350-8138666-92-9

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H302

H373**

H318

H317

GHS05

GHS08

GHS07

Dgr

H302

H373**

H318

H317

607-569-00-X

reaction mass of: sodium 2-amino-4-(2,6-difluoropyrimidin-4-ylamino)benzenesulfonate;

sodium 2-amino-4-(4,6-difluoropyrimidin-4-ylamino)benzenesulfonate

426-470-0—Skin Sens. 1H317

GHS07

Wng

H317
607-570-00-5sodium (6R-trans)-7-amino-8-oxo-3-[[[1-(sulfomethyl)-1H-tetrazol-5-yl]thio]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate monohydrate426-520-171420-85-4Skin Sens. 1H317

GHS07

Wng

H317
607-571-00-02-cyclopentene-1-acetic acid, 3-hydroxy-2-pentyl-, methyl ester acetate431-400-757374-49-9

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-572-00-6diethyl thiophosphoryl (Z)-(2-aminothiazol-4-yl)methoxyimino acetate426-790-0162208-27-7

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373**

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H312

H302

H373**

H317

H410

607-573-00-1

reaction mass of: disodium 7-(2,4-difluoropyrimidin-6-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate;

disodium 7-(4,6-difluoropyrimidin-2-ylamino)-4-hydroxy-3-(4-methoxy-2-sulfonatophenylazo)naphthalene-2-sulfonate

426-840-1—Eye Dam. 1H318

GHS05

Dgr

H318
607-574-00-7[1R-(1-α, 2β,5α)]-mono[5-methyl-2-(1-methylethyl)cyclohexyl]butanedioate426-890-477341-67-4Eye Dam. 1H318

GHS05

Dgr

H318
607-575-00-24-(5-(5-[1-(4-carboxyphenyl)hexahydro-2,4,6-trioxopyrimidin-5-ylidene]penta-1,3-dienyl)-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxopyrimidin-1-yl)benzoic acid-triethylamine salt426-900-7—

STOT SE 3

Aquatic Chronic 3

H335

H412

GHS07

Wng

H335

H412

607-576-00-8branched, octyl 3-[3,5-di(tert-butyl)-4-hydroxyphenyl]propanoate427-030-0—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
607-577-00-3(2R*, 3S*)-2-(2,4-difluorophenyl)-3-(5-fluoro-4-pyrimidinyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol (1R)-10-camphorsulfonate427-100-0—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

607-578-00-9ethyl 4-((4-diethylamino-2-methylphenyl)imino)-4,5-dihydro-1-isopropyl-5-oxo-1H-pyrazole-3-carboxylate427-110-5—

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 4

H302

H373**

H413

GHS08

GHS07

Wng

H302

H373**

H413

607-579-00-4diethyl[(p-ethoxyanilino)methylene]malonate431-430-0103976-28-9

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

607-580-00-Xethyl 7-chloro-1-(2,4-difluorophenyl)-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylate422-360-1100491-29-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-581-00-5ethyl 2-ethoxy-4-carboxymethylbenzoate427-630-299469-99-5Eye Dam. 1H318

GHS05

Dgr

H318
607-582-00-0

reaction mass of: tetrasodium 7-(4-(4-fluoro-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate;

tetrasodium 7-(4-(4-hydroxy-6-(4-(2-sulfonatoethylsulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate

427-650-1—Aquatic Chronic 3H412—H412
607-583-00-64-amino-3-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-1-naphthalene sulfonic acid427-680-5188907-52-0

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-584-00-1trisodium 3-[2-acetylamino-4-[4-chloro-6-[4-(2-sulfonatoxyethylsulfonyl)phenylamino]-1,3,5-triazine-2-ylamino]phenylazo]naphthalene-1,5-disulfonate427-710-7215612-56-9

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

607-585-00-7strontium 2-[(2-hydroxy-6-sulfonato-1-naphthyl)azo]naphthalene-1-sulfonate427-930-3—Skin Sens. 1H317

GHS07

Wng

H317
607-586-00-2dodecyl 3-amino-4-chlorobenzoate428-020-96195-20-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-587-00-8ethyl cis-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine-1-carboxylate428-030-367914-69-6

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373**

H410

607-588-00-3

reaction mass of: 2-ethylhexyl 2,3,4,5-tetrabromobenzoate;

bis(2-ethylhexyl) 3,4,5,6-tetrabromophthalate

428-050-2—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-589-00-9tetrakis(1,2,2,6,6-pentamethyl-4-piperidyl)-1,2,3,4-butanetetracarboxylate428-070-191788-83-9

STOT RE 1

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H372**

H302

H400

H410

GHS08

GHS07

GHS09

Dgr

H372**

H302

H410

607-590-00-4hexadecyl 3-[2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-4,4-dimethyl-3-oxovaleramido]-4-isopropoxybenzoate428-140-1210706-50-6Aquatic Chronic 4H413—H413
607-591-00-X

reaction mass of: trisodium 5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-3-(4-(2-sulfooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate;

disodium 3-(4-ethenesulfonylphenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxynaphthalene-2,7-disulfonate

428-400-4—Eye Dam.H318

GHS05

Dgr

H318
607-592-00-5di(C9-11-alkyl) cyclohexane-1,4-dicarboxylate428-870-0—Aquatic Chronic 4H413—H413
607-593-00-04-(2-methylacryloyloxy)phenyl 4-allyloxybenzoate429-000-2159235-16-2

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-594-00-6ethyl (1S, 5R, 6S)-5-(1-ethylpropoxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate429-020-1204254-96-6

STOT RE 2 *

Skin Sens. 1

H373**

H317

GHS08

GHS07

Wng

H373**

H317

607-595-00-1 N-amidino-N-methylglycine-2-oxopropionate429-120-5208535-04-0Eye Dam. 1H318

GHS05

Dgr

H318
607-596-00-7ethyl 2-(4-phenoxyphenyl)lactate429-220-9132584-17-9

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-597-00-2tetrasodium 4,4'-bis{]4-[}4-(2-hydroxyethylamino)-6-(4-sulfonatoanilino)-1,3,5-triazin-2-ylamino{]phenylazo[}stilbene-2,2'-disulfonate429-230-3—Eye Dam. 1H318

GHS05

Dgr

H318
607-598-00-8trisodium 3-amino-4-[4-[4-(2-(2-ethenylsulfonylethoxy)ethylamino)-6-fluoro-1,3,5-triazine-2-ylamino]-2-sulfophenylazo]-5-hydroxynaphthalene-2,7-disulfonate429-240-8212652-59-0Eye Dam. 1H318

GHS05

Dgr

H318
607-599-00-31,1-dimethylpropyl 3,5,5-trimethylperoxyhexanoate431-610-968860-54-8

Org. Perox. D

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H242

H317

H400

H410

GHS02

GHS07

GHS09

Dgr

H242

H317

H410

607-600-00-7(1S, 1'R)-[1-(3', 3'-dimethyl-1'-cyclohexyl)ethoxycarbonyl]methyl propanoate431-700-8—Aquatic Chronic 2H411GHS09H411
607-601-00-21,4-dihydroxy-2,2,6,6-tetramethyl piperidinium-2-hydroxy-1,2,3-propanetricarboxylate429-370-5220410-74-2Acute Tox. 4 *H302

GHS07

Wng

H302
607-602-00-8ethyl (3-cyanomethyl-3,4-dihydro-4-oxophthalazin-1-yl)acetate429-680-0122665-86-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-603-00-3lithium sodium 4,4', 4''-(nitrilotris(ethane-2,1-diylimino(6-chloro-1,3,5-triazine-4,2-diyl)imino))tris(5-hydroxy-6-(1-sulfonaphthalene-2-ylazo)-2,7-naphthalene)disulfonate429-730-1193562-37-7

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-604-00-9guanidinium benzoate429-820-026739-54-8Acute Tox. 4 *H302

GHS07

Wng

H302
607-605-00-4methyl 4-iodo-2-(3-(4-methoxy-6-methyl-1,3,5-triazine-2-yl)ureidosulfonyl)benzoate429-890-2144550-06-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
607-606-00-X(Z)-2-(2-t-butoxycarbonylamino-4-thiazolyl)pent-2-enoic acid430-100-386978-24-7Acute Tox. 4 *H302

GHS07

Wng

H302
607-607-00-5

reaction mass of: calcium bis(C10-14 branched alkyl salicylate);

calcium bis(C18-30-alkyl salicylate);

calcium C10-14 branched alkylsalicylato-C18-30-alkyl salicylate;

calcium bis (C10-14 branched alkyl phenolate);

calcium bis (C18-30-alkyl phenolate);

calcium C10-14 branched alkylphenolato-C18-30-alkyl phenolate;

C10-14 branched alkyl phenol;

C18-30-alkyl phenol

430-180-1—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-608-00-0pentapotassium 2-(4-{]5-[}1-(2,5-disulfophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene{]-3-(2-pyrrolidinone-1-yl)-1,3-pentadienyl[}-3-methylcarbamoyl-5-oxopyrazol-1-yl)benzene-1,4-disulfonate430-210-1—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
607-609-00-6ethyl (3R)-4-cyano-3-hydroxybutanoate430-220-6141942-85-0Eye Irrit. 2H319

GHS07

Wng

H319
607-610-00-1trisodium 4-hydroxy-6-(sulfonatomethylamino)-5-(2-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2-sulfonate430-280-3—Skin Sens. 1H317

GHS07

Wng

H317
607-611-00-7methyl 3-amino-2,2,3-trimethylbutyrate431-720-790886-53-6

Skin Corr. 1B

Acute Tox. 4 *

Aquatic Chronic 3

H314

H302

H412

GHS05

GHS07

Dgr

H314

H302

H412

607-612-00-2

reaction mass of: 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonic acid;

ammonium 3,3,4,4,5,5,6,6,7,7,8,8,8-tridecafluoro-1-octanesulfonate

432-190-1182176-52-9

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

H302

H373**

H318

GHS05

GHS08

GHS07

Dgr

H302

H373**

H318

607-613-00-8

reaction mass of: succinic acid;

monopersuccinic acid;

dipersuccinic acid;

monomethyl ester of succinic acid;

monomethyl ester of persuccinic acid;

dimethyl succinate;

glutaric acid;

monoperglutaric acid;

diperglutaric acid;

monomethyl ester of glutaric acid;

monomethyl ester of perglutaric acid;

dimethyl glutarate;

adipic acid;

monoperadipic acid;

diperadipic acid;

monomethyl ester of adipic acid;

monomethyl ester of peradipic acid;

dimethyl adipate;

hydrogen peroxide;

methanol;

water

432-790-1—

Muta. 2

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

H341

H314

H332

H312

H302

GHS05

GHS08

GHS07

Dgr

H341

H314

H332

H312

H302

607-614-00-32-(10-oxo-10H-9-oxa-10-phosphaphenanthren-10-ylmethyl)succinic acid426-480-563562-33-4

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

607-615-00-9reaction product of thioglycerol and mercaptoacetic acid consisting mainly of 3-mercapto-1,2-bismercaptoacetoxypropane and oligomers of this substance431-120-5—

Acute Tox. 3 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

H331

H302

H319

H317

GHS06

Dgr

H331

H302

H319

H317

607-616-00-42,4-dichloro-5-fluorobenzoylchloride428-390-186393-34-2

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H335

H315

H318

H317

H412

GHS05

GHS07

Dgr

H335

H315

H318

H317

H412

607-617-00-Xbis(2-ethylhexyl)-4,5-epoxycyclohexane-1,2-dicarboxylate430-700-510138-36-0Skin Sens. 1H317

GHS07

Wng

H317
607-618-00-5

menadione sodium bisulfite;

2-naphthalenesulfonic acid, 1,2,3,4-tetrahydro-2-methyl-1,4-dioxo-, sodium salt

204-987-0130-37-0

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

607-619-00-0

menadione nicotinamide bisulfite;

1,2,3,4-tetrahydro-2-methyl-1,4-dioxonaphthalene-2-sulfonic acid, compound with nicotin-3-amide (1:1)

277-543-773581-79-0

Eye Irrit. 2

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H319

H315

H400

H410

GHS07

GHS09

Wng

H319

H315

H410

607-620-00-6trisodium nitrilotriacetate225-768-65064-31-3

Carc. 2

Acute Tox. 4 *

Eye Irrit. 2

H351

H302

H319

GHS08

GHS07

Wng

H351

H302

H319

Carc. 2; H351: C ≥ 5 %
607-621-00-1

milbemectin (ISO);

[reaction mass of milbemycin A3 (CAS No 51596-10-2) and milbemycin A4 (CAS No 51596-11-3) (30:70)]

——

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H332

H302

H400

H410

GHS07

GHS09

Wng

H332

H302

H410

M=100
607-622-00-72-ethylhexyl-2-ethylhexanoate231-057-17425-14-1Repr. 2H361d***

GHS08

Wng

H361d***
607-623-00-2diisobutyl phthalate201-553-284-69-5Repr. 1BH360Df

GHS08

Dgr

H360Df

Repr. 1B; H360Df: C ≥ 25 %

Repr. 2; H361f: 5 % ≤ C < 25 %

607-624-00-8

perfluorooctane sulfonic acid;

heptadecafluorooctane-1-sulfonic acid; [1]

potassium perfluorooctanesulfonate;

potassium heptadecafluorooctane-1-sulfonate; [2]

diethanolamine perfluorooctane sulfonate; [3]

ammonium perfluorooctane sulfonate;

ammonium heptadecafluorooctanesulfonate; [4]

lithium perfluorooctane sulfonate;

lithium heptadecafluorooctanesulfonate [5]

217-179-8 [1]

220-527-1 [2]

274-460-8 [3]

249-415-0 [4]

249-644-6 [5]

1763-23-1 [1]

2795-39-3 [2]

70225-14-8 [3]

29081-56-9 [4]

29457-72-5 [5]

Carc. 2

Repr. 1B

STOT RE 1

Acute Tox. 4 *

Acute Tox. 4 *

Lact.

Aquatic Chronic 2

H351

H360D***

H372**

H332

H302

H362

H411

GHS08

GHS07

GHS09

Dgr

H351

H360D***

H372**

H332

H302

H362

H411

607-625-00-3clodinafop-propargyl (ISO)—105512-06-9

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373**

H317

H410

Skin Sens. 1; H317: C ≥ 0,001 %

M=1

607-626-00-9ethyl 1-(2,4-dichlorophenyl)-5-(trichloromethyl)-1H-1,2,4-triazole-3-carboxylate401-290-5103112-35-2

Carc. 1B

Aquatic Acute 1

Aquatic Chronic 1

H350

H400

H410

GHS08

GHS09

Dgr

H350

H410

607-627-00-4[(4S, 5S)-4-benzyl-2-oxo-5-oxazolidinyl]methyl 4-nitrobenzenesulfonate416-360-0162221-28-5Skin Sens. 1H317

GHS07

Wng

H317
607-628-00-X4-oxo-4-(p-tolyl)butyric acid adduct with 4-ethylmorpholine419-240-6171054-89-0Eye Dam. 1H318

GHS05

Dgr

H318
607-629-00-5[[2-methyl-1-(1-oxopropoxy)propoxy](4-phenylbutyl)phosphinyl] acetic acid419-270-1123599-82-6Eye Irrit. 2H319

GHS07

Wng

H319
607-630-00-0acrylic acid, 3-(trimethoxysilyl)propyl ester419-560-64369-14-6

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 3

H332

H314

H317

H412

GHS05

GHS07

Dgr

H332

H314

H317

H412

607-631-00-6

reaction mass of: 2-(2-((oxo(phenyl)acetyl)oxy)ethoxy)ethyl oxo(phenyl)acetate;

(2-(2-hydroxyethoxy)ethyl) oxo(phenyl)acetate

442-300-8—Skin Sens. 1H317

GHS07

Wng

H317
607-632-00-1 N-[3-(2,4-di-(1,1-dimethyl-propyl)phenoxy)-propyl]-1-hydroxy-5-(2-methylpropyl-oxycarbonylamino)-naphthamide420-210-1111244-14-5Aquatic Chronic 4H413—H413
607-633-00-7trisodium 5-{][}4-chloro-6-(1-naphthylamino)-1,3,5-triazin-2-yl{]amino[}-4-hydroxy-3-[(E)-(4-methoxy-2-sulfonatophenyl)diazenyl]-2,7-naphthalenedisulfonate440-480-2341026-59-3

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-634-00-2

(S)-(–)-2-acetoxypropionylchloride;

(1S)-2-chloro-1-methyl-2-oxoethyl acetate

420-610-436394-75-9

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

H302

H314

H317

GHS05

GHS07

Dgr

H302

H314

H317

607-635-00-8trisodium N-(3-propionato)-l-aspartate422-090-4172737-80-3Eye Dam. 1H318

GHS05

Dgr

H318
607-636-00-31-bromo-2-methylpropyl propionate422-900-6158894-67-8

Flam. Liq. 3

Carc. 2

Skin Corr. 1B

Skin Sens. 1

H226

H351

H314

H317

GHS02

GHS05

GHS08

GHS07

Dgr

H226

H351

H314

H317

607-637-00-9disodium 8-amino-5-{]4-[}2-(sulfonatoethoxy)sulfonyl{]phenylazo[}naphthalene-2-sulfonate423-730-5250688-43-8Eye Dam. 1H318

GHS05

Dgr

H318
607-638-00-42-hydroxybenzoic acid 2-butyloctyl ester431-090-3190085-41-7Aquatic Chronic 4H413—H413
607-639-00-X2-(2-oxo-5-(1,1,3,3-tetramethylbutyl)-2,3-dihydro-1-benzofuran-3-yl)-4-(1,1,3,3-tetramethylbutyl)phenyl acetate431-770-1216698-07-6Aquatic Chronic 4H413—H413
607-641-00-0

2-(formylamino)-3-thiophenecarboxylic acid;

2-formamido-3-thiophenecarboxylic acid

431-930-943028-69-9

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

607-642-00-63,6,9-trithiaundecamethylene-1,11-dimethacrylate432-210-7141631-22-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
607-643-00-1dimethyl (2S)-2-hydroxysuccinate432-310-0617-55-0

Flam. Liq. 3

Eye Dam. 1

Skin Sens. 1

H226

H318

H317

GHS02

GHS05

GHS07

Dgr

H226

H318

H317

607-644-00-7methyl 2,2-dimethyl-6-methylenecyclohexanecarboxylate432-350-981752-87-6Skin Irrit. 2H315

GHS07

Wng

H315
607-645-00-2tetrasodium 2-(4-fluoro-6-(methyl-(2-(sulfatoethylsulfonyl)ethyl)amino)-1,3,5-triazin-2-ylamino)-5-hydroxy-6-(4-methyl-2-sulfonatophenylazo)naphthalene-1,7-disulfonate432-550-6243858-01-7Eye Dam. 1H318

GHS05

Dgr

H318
607-646-00-8

d-erythro-hexanoic acid 2,4-dideoxy-3,5-O-(1-methylethylidene)-1,1-dimethylethylester;

tert-butyl 2-[(4R, 6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl]acetate

432-960-5124655-09-0Acute Tox. 4 *H302

GHS07

Wng

H302
607-647-00-35-acetoxy-2-(R, S)butyryloxymethyl-1,3-oxathiolane433-530-1143446-73-5

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

H302

H317

H400

GHS07

GHS09

Wng

H302

H317

H400

607-649-00-4[3-(chlorocarbonyl)-2-methylphenyl]acetate433-690-0167678-46-8

Skin Corr. 1A

Skin Sens. 1

H314

H317

GHS05

GHS07

Dgr

H314

H317

607-650-00-X2-methyl-1,5-pentanediamine-1,3-benzenedicarboxylate433-910-5145153-52-2Skin Sens. 1H317

GHS07

Wng

H317
607-651-00-5sodium 2-(nonanoyloxy)benzenesulfonate434-360-991125-43-8

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-652-00-0ethyl N 2-dodecanoyl-l-argininate hydrochloride434-630-660372-77-2

Eye Dam. 1

Aquatic Acute 1

H318

H400

GHS05

GHS09

Dgr

H318

H400

607-653-00-6tetrakis(bis(2-hydroxyethyl)methylammonium) 3-(4-(7-acetylamino-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-5-methoxy-2-sulfonatophenylazo)-7-(4-amino-3-sulfonatophenylamino)-4-hydroxynaphthalene-2-sulfonate434-840-8225786-91-4Aquatic Chronic 2H411GHS09H411
607-654-00-1(S)-3-hydroxy-γ-butyrolactone434-990-47331-52-4Skin Sens. 1H317

GHS07

Wng

H317
607-655-00-7ethyl 6,8-dichlorooctanoate435-080-11070-64-0

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-656-00-2sodium salt of 4-amino-3,6-bis[[5-[[4-chloro-6-[(2-methyl-4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]azo]-5-hydroxy-2,7-naphthalenedisulfonic acid435-350-7141250-43-3

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-657-00-8pentasodium 7-(4-(4-(3-(2-sulfatoethanesulfonyl)phenylamino)-6-(4-(2-sulfatoethanesulfonyl)phenylamino)-1,3,5-triazin-2-ylamino)-2-ureidophenylazo)naphthalene-1,3,6-trisulfonate436-920-8172399-10-9Eye Dam. 1H318

GHS05

Dgr

H318
607-658-00-33,10-diamino-6,13-dichloro-2-((6-(((4-(1,1-dimethylethyl)phenyl)sulfonyl)amino)-2-naphthalenyl)sulfonyl)-4,11-triphenodioxazinedisulfonic acid, lithium potassium sodium salt440-770-9371921-63-0

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-659-00-9pentasodium N-[5-[[4-[[3-[(aminocarbonyl)amino]-4-[(3,6,8-trisulfonatonaphthalen-2-yl)azo]phenyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-2-sulfonato-4-[[4-[[-2-(oxysulfonato)ethyl] sulfonyl]phenyl]azo]phenyl]-3-aminopropanoic acid442-030-0321912-47-4Eye Dam. 1H318

GHS05

Dgr

H318
607-660-00-42-{]4-[}4-[4-fluoro-6-(2-(2-vinylsulfonylethoxy)ethylamino)-1,3,5-triazin-2-ylamino{]phenylazophenylazo[}naphthalene-4,6,8-trisulfonate, trisodium salt442-230-8321679-52-1Eye Dam. 1H318

GHS05

Dgr

H318
607-661-00-X1,1-dimethylethyl 4'-(bromomethyl)biphenyl-2-carboxylate442-850-9114772-40-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-662-00-5methyl 2-(acetylamino)-3-chloropropionate442-860-387333-22-0

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

607-663-00-0bis(2-ethylhexyl) naphthalene-2,6-dicarboxylate442-980-6127474-91-3Aquatic Chronic 4H413—H413
607-664-00-6methyl 2-chlorosulfonyl-4-(methanesulfonylaminomethyl) benzoate443-120-2393509-79-0

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

607-665-00-1 trans-methyl-2-ethyl-but-2-enoate443-150-6101226-85-1Flam. Liq. 3H226

GHS02

Wng

H226
607-666-00-7(2S)-5-(benzyloxy)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-5-oxopentanoic acid443-560-588784-33-2Eye Irrit. 2H319

GHS07

Wng

H319
607-667-00-2chloro-1-ethylcyclohexyl carbonate444-950-899464-83-2

Muta. 2

Skin Sens. 1

H341

H317

GHS08

GHS07

Wng

H341

H317

607-668-00-8 trans-2-isopropyl-5-carboxy-1,3-dioxane445-770-242031-28-7

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

607-669-00-3methyl (9-acetoxy-3,8,10-triethyl-7,8,10-trimethyl-1,5-dioxa-9-aza-spiro[5.5]undec-3-yl)octadecanoate445-990-9376588-17-9

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

607-670-00-9

dibutyl-3-(4-(5-ammonio-2-butyl)benzofuran-3-yl)carbonyl)phenoxy)propyl ammonium oxalate;

(5-amino-2-butylbenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl]methanone, dioxalate

448-700-9500791-70-8

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H373**

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H373**

H318

H317

H410

M=10
607-671-00-4diethyl 1,4-cyclohexanedicarboxylate417-310-072903-27-6Aquatic Chronic 2H411GHS09H411
607-672-00-X

reaction mass of: 2-hydroxy-3-(methacryloyloxy)propyl (2-benzoyl)benzoate;

1-hydroxymethyl-2-(methacryloyloxy)ethyl (2-benzoyl)benzoate;

x-hydroxy-y-(methacryloyloxy)propyl(or -ethyl) (2-benzoyl)benzoate

419-000-0—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-673-00-51-ethyl-5,6,7,8-tetrahydroquinolinium tosylate419-570-0—

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

607-675-00-6

reaction mass of: cis-9-octadecenedioic acid;

cis-9-cis-12-octadecadienedioic acid;

hexadecanedioic acid;

octadecanedioic acid

422-260-8—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

607-676-00-1

reaction mass of: 2-methylnonanedioic acid;

2,4-dimethyl-4-methoxycarbonylundecanedioic acid;

2,4,6-trimethyl-4,6-dimethoxycarbonyltridecanedioic acid;

8,9-dimethyl-8,9-dimethoxycarbonylhexadecanedioic acid

423-670-1—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

607-677-00-72,5-dioxopyrrolidin-1-yl N-{][}methyl[[2-(1-methylethyl)-4-thiazolyl{]methylaminocarbonyl[}-l-valinate424-660-8—

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H373**

H318

H317

GHS05

GHS08

GHS07

Dgr

H373**

H318

H317

607-678-00-2

reaction mass of: ethyl (2R, 3R)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate;

ethyl (2S, 3S)-3-isopropylbicyclo[2.2.1]hept-5-ene-2-carboxylate

427-090-8—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-679-00-8

reaction mass of: 3-{]5-[}3-(4-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(methyl)ammonium di(acetate);

3-{]5-[}4-(3-{]1,6-dihydro-2-hydroxy-4-methyl-1-[}3-(methylammonio)propyl{]-6-oxo-3-pyridylazo[}benzamido{]phenylazo-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate);

3-{]5-[}3-(4-{]1-[}3-(dimethylammonio)propyl{]-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo[}benzamido)phenylazo{]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl[}propyl(dimethyl)ammonium di(acetate)

431-440-5—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

607-680-00-3 tert-butyl(6-{]2-[}4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino{]pyrimidin-5-ylvinyl[}(4S, 6S)-2,2-dimethyl[1,3]dioxan-4-yl)acetate432-810-9—Aquatic Chronic 4H413—H413
607-681-00-9

reaction mass of: 9-nonyl-10-octyl-19-carbonyloxyhexadecylnonadecanoic acid;

9-nonyl-10-octyl-19-carbonyloxyoctadecylnonadecanoic acid;

dihexadecyl 9-nonyl-10-octylnonadecandioate;

1-octadecyl, 19-hexadecyl 9-nonyl-10-octylnonadecandioate;

dioctadecyl 9-nonyl-10-octylnonadecandioate

432-910-2—Aquatic Chronic 4H413—H413
607-682-00-4complex reaction mass of Chinese gum rosin post reacted with acrylic acid434-230-1144413-22-9Aquatic Chronic 4H413—H413
607-683-00-X

reaction mass of: methyl 3-((1E)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate;

methyl 3-((1Z)-2-methylprop-1-enyl)-2,2-dimethylcyclopropanecarboxylate (20:80)

435-450-0—

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

607-684-00-5alkenes, C12-14, hydroformylation products, distn. residues, C-(hydrogen sulfobutanedioates), disodium salts435-660-2243662-67-1

Skin Irrit. 2

Skin Sens. 1

H315

H317

GHS07

Wng

H315

H317

607-685-00-0ammonium 2-cocoyloxyethanesulfonate441-050-7—

Skin Irrit. 2

Eye Dam. 1

H315

H318

GHS05

Dgr

H315

H318

607-686-00-66,6'-bis(diazo-5,5', 6,6'-tetrahydro-5,5'-dioxo)[methylene-bis(5-(6-diazo-5,6-dihydro-5-oxo-1-naphthylsulphonyloxy)-6-methyl-2-phenylene]di(naphthalene-1-sulfonate)441-550-5—

Self-react. C ****

Carc. 2

H242

H351

GHS02

GHS08

Dgr

H242

H351

607-687-00-1

reaction mass of: 2-{]3,6-bis-[}(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);

2-{]3,6-bis-[}(2,3-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);

2-{]3,6-bis-[}(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);

2-{]3,6-bis-[}(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (2-10 %);

2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);

2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);

2-{]3-[}(2,5-dimethylphenyl)-methylamino]-6-[(2-ethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);

2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,4-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);

2-{]3-[}(2,3-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %);

2-{]3-[}(2,4-dimethylphenyl)-methylamino]-6-[(2,5-dimethylphenyl)-methylamino{]-xanthylium-9-yl[}-benzenesulfonate (7-20 %)

442-800-6—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

607-688-00-7(R)-1-cyclohexa-1,4-dienyl-1-methoxycarbonyl-methylammoniumchloride444-320-2—Acute Tox. 4 *H302

GHS07

Wng

H302
607-689-00-2

reaction mass of: methyl 1,4-dimethylcyclohexanecarboxylate (‘para-isomer’ including cis- and trans- isomers);

methyl 1,3-dimethylcyclohexanecarboxylate (‘meta-isomer’ including cis- and trans-isomers)

444-920-4—Aquatic Chronic 3H412—H412
607-690-00-8dimethyl[2S, 2S']-6,6,6'6'-tetramethoxy-2,2'-[N,N'-bis(trifluoracetyl)-S, S'-bi(L-homocysteinyl) diimino]dihexanoate432-860-1255387-46-3Skin Sens. 1H317

GHS07

Wng

H317
607-691-00-3magnesium salts, fatty acids, C16-18 and C18 unsaturated, branched and linear448-690-6—Aquatic Chronic 4H413—H413
607-692-00-9zinc salts, fatty acids, C16-18 and C18 unsaturated, branched and linear446-470-4—Aquatic Chronic 4H413—H413
607-693-00-4hexyl 2-(1-(diethylaminohydroxyphenyl)methanoyl)benzoate443-860-6302776-68-7Aquatic Chronic 4H413—H413
607-694-00-Xethyl 5,5-diphenyl-2-isoxazoline-3-carboxylate443-870-0163520-33-0

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

608-020-00-7diphenoxymethylenecyanamide427-300-879463-77-7

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

608-032-00-2

acetamiprid (ISO);

(E)-N1-[(6-chloro-3-pyridyl)methyl]-N2-cyano-N1-methylacetamidine

—135410-20-7

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

608-042-00-7(S)-2,2-diphenyl-2-(3-pyrrolidinyl)acetonitrile hydrobromide421-810-4194602-27-2

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

608-044-00-82-cyclohexylidene-2-phenylacetonitrile423-740-110461-98-0

Acute Tox. 4 *

Aquatic Chronic 2

H302

H411

GHS07

GHS09

Wng

H302

H411

608-046-00-95-(4-chloro-2-nitro-phenylazo)-1,2-dihydro-6-hydroxy-1,4-dimethyl-2-oxo-pyridine-3-carbonitrile425-310-777889-90-8Aquatic Chronic 4H413—H413
608-047-00-42-piperidin-1-yl-benzonitrile427-330-172752-52-4Aquatic Chronic 2H411GHS09H411
608-048-00-X1-(3-cyclopentyloxy-4-methoxyphenyl)-4-oxo-cyclohexanecarbonitrile427-450-4152630-47-2

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 2

H302

H373**

H317

H411

GHS08

GHS07

GHS09

Wng

H302

H373**

H317

H411

608-049-00-52-(4-(4-(butyl-(1-methylhexyl)amino)phenyl)-3-cyano-5-oxo-1,5-dihydropyrrol-2-ylidene)propandinitrile429-180-2157362-53-3

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

608-050-00-0

reaction mass of: 5-(2-cyano-4-nitrophenylazo)-2-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-6-phenylaminonicotinonitrile;

5-(2-cyano-4-nitrophenylazo)-6-(2-(2-hydroxyethoxy)ethylamino)-4-methyl-2-phenylaminonicotinonitrile

429-760-5—Aquatic Chronic 4H413—H413
608-051-00-6(R)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile430-760-2219861-18-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

608-052-00-1(S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile430-770-7128173-52-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

608-053-00-7(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile430-780-1103146-25-4

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

608-054-00-2(R,S)-4-(4-dimethylamino-1-(4-fluorophenyl)-1-hydroxybutyl)-3-(hydroxymethyl)benzonitrile hemisulfate430-790-6—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H302

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H317

H411

608-055-00-8

fipronil (ISO);

5-amino-1-[2,6-dichloro-4-(trifluoromethyl)phenyl]-4-[(trifluoromethyl)sulfinyl]-1H-pyrazole-3-carbonitrile

—120068-37-3

Acute Tox. 3 *

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H311

H301

H372**

H400

H410

GHS06

GHS08

GHS09

Dgr

H331

H311

H301

H372**

H410

M=10
608-056-00-3 N-methyl-N-cyanomethylmorpholiniummethylsulfate429-340-1—

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

608-057-00-94-cyanomethyl-4-methylmorpholin-4-iumhydrogene sulfate431-200-1208538-34-5

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

H302

H318

H317

GHS05

GHS07

Dgr

H302

H318

H317

608-059-00-X5-amino-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-1H-pyrazole-3-carbonitrile421-240-6120068-79-3Aquatic Chronic 2H411GHS09H411
608-060-00-55-methyl-2-[(2-nitrophenyl)amino]-3-thiophenecarbonitrile421-300-1138564-59-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
608-062-00-62-fluoro-4-hydroxybenzonitrile422-810-782380-18-5

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

608-063-00-1(S)-α-hydroxy-3-phenoxy-benzeneacetonitrile441-070-661826-76-4

Acute Tox. 3 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H301

H318

H317

H400

H410

GHS06

GHS05

GHS09

Dgr

H301

H318

H317

H410

608-064-00-7cyanomethyltrimethylammoniummethylsulfate433-720-2—Aquatic Chronic 3H412—H412
609-069-00-7

musk ketone;

3,5-dinitro-2,6-dimethyl-4-tert-butylacetophenone;

4'-tert-butyl-2', 6'-dimethyl-3', 5'-dinitroacetophenone

201-328-981-14-1

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

609-072-00-34-mesyl-2-nitrotoluene430-550-01671-49-4

Repr. 2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H361f***

H302

H317

H412

GHS08

GHS07

Dgr

H361f***

H302

H317

H412

609-073-00-9lithium potassium sodium N,N''-bis{]6-[}7-[4-(4-chloro-1,3,5-triazin-2-yl)amino-4-(2-ureidophenylazo){]naphthalene-1,3,6-trisulfonato[}-N'-(2-aminoethyl)piperazine427-850-9—Skin Sens. 1H317

GHS07

Wng

H317
611-050-00-3

reaction mass of: pentasodium 7-amino-3-[[4-[[4-[[4-[[4-[(6-amino-1-hydroxy-3-sulfonato-2-naphthyl)azo]-7-sulfonato-1-naphthyl]azo]phenyl]amino]-3-sulfonatophenyl]azo]-6-sulfonato-1-naphthyl]azo]-4-hydroxynaphthalen-2-sulfonate;

pentasodium 7-amino-8-[4-[4-[4-[4-(2-amino-5-hydroxy-7-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;

pentasodium 7-amino-8-[4-[4-[4-[4-(6-amino-1-hydroxy-3-sulfonato-naphthalen-1-ylazo)-7-sulfonatonaphthalen-1-ylazo]-phenylamino]-3-sulfonato-phenylazo]-6-sulfonato-naphthalen-1-ylazo]-4-hydroxy-naphthalene-2-sulfonate;

tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-hydroxy-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate;

tetrasodium 7-amino-4-hydroxy-3-[4-[4-[4-(4-amino-7-sulfonato-naphthalen-1-ylazo)-2-sulfonato-phenylamino]phenylazo]-6-sulfonato-naphthalen-1-ylazo]naphthalene-2-sulfonate

415-350-3—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-102-00-5

reaction product of: C.I. Leuco Sulfur Black 1 and reaction mass of: disodium-4-{]4-[}8-amino-1-hydroxy-7-(4-sulfamoylphenylazo)-3,6-disulfonato-2-naphthylazo{]phenylsulfonylamino[}benzendiazoniumchlorid;

disodium-4-{]4-[}2,6-dihydroxy-3-(8-hydroxy-3,6-disulfonato-1-naphthylazo)phenylazo{]phenylsulfonylamino[}benzen-diazoniumchlorid

424-500-7—Aquatic Chronic 3H412—H412
611-139-00-7reaction product of: C.I. Leuco Sulfur Black 1 with (3-chloro-2-hydroxypropyl)trimethylammonium chloride424-510-1—

Eye Dam. 1

Aquatic Chronic 2

H318

H411

GHS05

GHS09

Dgr

H318

H411

611-141-00-85-(4-[4-[4-(3,5-dicarboxy-phenyl-azo)phenylamino]-6-morpholin-4-yl-1,3,5-triazin-2-ylamino]phenylazo)isophthalic acid, mixed monosodium and diammonium salt414-410-6—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-142-00-3

product-by-process definition polyazodyestuff obtained by coupling 4-[4-(1-amino-8-hydroxy-3,6-disulfo-2-naphthylazo)phenylsulfonylamino]benzenediazonium with reaction mass of 4-carboxybenzenediazonium and diphenylamine-3-sulfo-4,4'-bisdiazonium, and further coupling of the obtained compounds with reaction mass of naphth-2-ol and 3-aminophenol, sodium salts;

sodium chloride

425-740-5—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-143-00-9

reaction mass of: trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(2,6-difluoropyrimidin-4-ylamino)-4-sulfonatophenolatocuprate (II);

trisodium 2-(2-[α-(2-carboxylato-κ-O-4-sulfonatophenylazo)benzylidene]hydrazino-κ-N')-6-(4,6-difluoropyrimidin-2-ylamino)-4-sulfonatophenolatocuprate (II)

428-260-4—Eye Dam. 1H318

GHS05

Dgr

H318
611-144-00-4

reaction mass of: 7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt;

7-amino-3-[4-(2-sulfoxyethylsulfonyl)phenylazo]-4-hydroxy-8-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;

7-amino-8-[4-(2-sulfoxyethylsulfonyl)-phenylazo]-4-hydroxy-3-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]naphthalene-2-sulfonic acid, Na/K salt;

7-amino-3,8-bis-[4-(2-sulfoxyethylsulfonyl)-2-sulfophenylazo]-4-hydroxynaphthalene-2-sulfonic acid, Na/K salt

429-070-4214362-06-8Eye Dam. 1H318

GHS05

Dgr

H318
611-145-00-X

reaction mass of: tetrasodium 3-(1,5-disulfonatonaphthalene-2-ylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonate;

3-(2,5-disulfophenylazo)-4-hydroxy-7-{]4-chloro-6-[}4-(2-sulfoxyethylsulfonyl)phenylamino{]-1,3,5-triazine-2-ylamino[}naphthalene-2-sulfonic acid, sodium salt

429-440-5—Eye Dam. 1H318

GHS05

Dgr

H318
611-146-00-5

reaction mass of: pentasodium 3-(4-(4-(7-(2,4-diamino-5-sulfonato-3-(4-sulfonatophenylazo)phenylazo)-1-hydroxy-3-sulfonatonaphthalen-2-ylazo)-2-sulfonatophenylamino)phenylazo)-4-hydroxy-6-(2-oxo-1-phenylcarbamoylpropylazo)naphthalene-2-sulfonate;

pentasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonatophenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)phenyl)amino)-2-sulfonatophenyl)azo)-4-hydroxynaphthalene-2-sulfonate;

pentasodium 6-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-3-((4-((4-((1,7-dihydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate;

hexasodium 6-((2,4-diamino-5-sulfonatophenyl)azo)-3-((4-((4-((7-((2,4-diamino-5-sulfonato-3-((4-sulfonatophenyl)azo)phenyl)azo)-1-hydroxy-3-sulfonatonaphthalen-2-yl)azo)-2-sulfonatophenyl)amino)phenyl)azo)-4-hydroxynaphthalene-2-sulfonate

430-070-1—Aquatic Chronic 2H411GHS09H411
611-147-00-0sodium, potassium, lithium 5-amino-3,6-bis(5-(4-chloro-6-(methyl-(2-methylaminoacetyl)amino)-1,3,5-triazin-2-ylamino)-2-sulfonatophenylazo)-4-hydroxynaphthalene-2,7-disulfonate430-090-0205764-96-1

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-148-00-6

reaction mass of: 2-(3-(2,6-dichloro-4-nitrophenylazo)carbazol-9-yl)ethanol;

2-(2-(3-(2,6-dichloro-4-nitro-phenylazo)-carbazol-9-yl)-ethoxy)ethanol;

3-(2,6-dichloro-4-nitrophenylazo)carbazol

429-590-1—

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

611-149-00-12-(2-chloroacetoxy)ethyl 3-((4-(2,5-dichloro-4-fluorosulfonylphenylazo)-3-methylphenyl)ethylamino)propionate427-570-7193486-83-8Aquatic Chronic 2H411GHS09H411
611-150-00-7tetralithium 2-[6-[7-[2-(carboxylato)phenylazo]-8-hydroxy-3,6-disulfonato-1-naphthylamino]-4-hydroxy-1,3,5-triazine-2-ylamino]benzoate440-460-3—

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

611-151-00-2

chrysoidine;

4-(phenylazo)benzene-1,3-diamine

207-803-7495-54-5

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H341

H302

H315

H400

H410

GHS08

GHS07

GHS09

Wng

H341

H302

H315

H410

611-152-00-8

chrysoidine monohydrochloride;

4-phenylazophenylene-1,3-diamine monohydrochloride; [1]

chrysoidine monoacetate;

4-(phenylazo)benzene-1,3-diamine monoacetate; [2]

chrysoidine acetate;

4-(phenylazo)benzene-1,3-diamine acetate; [3]

chrysoidine-p-dodecylbenzenesulfonate;

dodecylbenzenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1); [4]

chrysoidine dihydrochloride;

4-(phenylazo)benzene-1,3-diamine dihydrochloride; [5]

chrysoidine sulfate;

bis[4-(phenylazo)benzene-1,3-diamine] sulfate [6]

208-545-8 [1]

278-290-5 [2]

279-116-0 [3]

264-409-8 [4]

281-549-5 [5]

282-432-1 [6]

532-82-1 [1]

75660-25-2 [2]

79234-33-6 [3]

63681-54-9 [4]

83968-67-6 [5]

84196-22-5 [6]

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H341

H302

H315

H318

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H341

H302

H315

H318

H410

611-153-00-3

chrysoidine C10-14-alkyl derivatives;

benzenesulfonic acid, mono-C10-14-alkyl derivatives, compounds with 4-(phenylazo)-1,3-benzenediamine; [1]

chrysoidine compound with dibutylnaphthalene sulfonic acid;

dibutylnaphthalenesulfonic acid, compound with 4-(phenylazo)benzene-1,3-diamine (1:1) [2]

286-946-7 [1]

304-236-8 [2]

85407-90-5 [1]

94247-67-3 [2]

Muta. 2

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

H341

H302

H315

H318

GHS05

GHS08

GHS07

Dgr

H341

H302

H315

H318

611-154-00-9trisodium 5-benzamido-4-hydroxy-3-(4-methyl-2-sulfonatophenylazo)naphthalene-2,7-disulfonate403-670-692408-46-3Aquatic Chronic 3H412—H412
611-155-00-44,4'-oxybis(benzenesulfonylazide)431-850-47456-68-0

Expl. 1.1****

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H201

H373**

H400

H410

GHS01

GHS08

GHS09

Dgr

H201

H373**

H410

611-156-00-Xtriammonium 4-[4-[7-(4-carboxylatoanilino)-1-hydroxy-3-sulfonato-2-naphthylazo]-2,5-dimethoxyphenylazo]benzoate432-270-4221354-37-6

Repr. 2

STOT RE 2 *

Aquatic Chronic 2

H361f***

H373**

H411

GHS08

GHS09

Wng

H361f***

H373**

H411

611-157-00-5

benzenesulfonic acid, 3,3'-(methylenebis((dihydroxyphenylene)azo))bis-, potassium sodium salt;

potassium sodium 3-[(E)-(6-{]3,4-dihydroxy-2-[}(Z)-(3-sulfonatophenyl)diazenyl{]benzyl[}-2,3-dihydroxyphenyl)diazenyl]benzenesulfonate

432-590-4243869-48-9

Eye Irrit. 2

Aquatic Chronic 3

H319

H412

GHS07

Wng

H319

H412

611-158-00-0reaction product of: 2,3,4,2', 3', 4'-hexahydroxy-5,5'-diacethyl-diphenylmethane and 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonylchloride and 3-diazo-3,4-dihydro-6-methoxy-4-oxo-1-naphthalenesulfonylchloride421-520-8—

****

Aquatic Chronic 4

****

H413

****

****

H413

611-159-00-6disodium 4-amino-6-((4-((4-(2,4-diaminophenyl)azo)phenylsulfamoyl)phenyl)azo)-5-hydroxy-3-((4-nitrophenyl)azo)naphthalene-2,7-disulfonate421-880-6—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-160-00-1

reaction mass of: 1,1,1-tris(phenyl-4'-(3''-diazo-3'', 4''-dihydro-4''-oxo-naphthalene-1''-sulfonato)ethane;

1,1,1-tris(phenyl-4'-(6''-diazo-5'', 6''-dihydro-5''-oxo-naphthalene-1''-sulfonato)ethane;

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (2:1);

reaction product of 1,1,1-tris(p-hydroxyphenyl)ethane with 6-diazo-5,6-dihydro-5-oxo-1-naphthylsulfonylchloride and 3-diazo-3,4-dihydro-4-oxo-1-naphthylsulfonylchloride (1:2)

422-760-6—

****

Aquatic Chronic 4

****

H413

****

****

H413

611-161-00-7trisodium [1,2'-(2-(8-amino-3,5-disulfonatonaphthalene)azo)-(4'-nitrobenzene)diolato-O,O,N][(Z)-2,2-((phenylcarbamoylprop-1'-enyl)azo)-5-sulfamoylbenzene)diolato-O,O,N]chromate(III)423-100-1—Eye Dam. 1H318

GHS05

Dgr

H318
611-162-00-22,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diolbis(methanesulfonate)429-600-4—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

611-163-00-82,4-bis(((2-(dimethylammonio)ethyloxy)carbonyl)phen-2-ylazo)benzene-1,3-diol sulfate429-610-9—

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 2

H302

H318

H411

GHS05

GHS07

GHS09

Dgr

H302

H318

H411

611-164-00-3

reaction mass of: 2,2'-dimethyl-2,2'-azobutanenitrile;

2-methylpentanenitrile-2-azo-2'-(2'-methylpropanenitrile);

2,2'-dimethyl-2,2'-azoheptanenitrile;

2-methylheptanenitrile-2-azo-2'-(2'-methylpropanenitrile);

2-methylheptanenitrile-2-azo-2'-(2'-methylbutanenitrile)

429-710-2—

Self React D

Acute Tox. 4 *

Aquatic Chronic 2

H242

H302

H411

GHS02

GHS07

GHS09

Dgr

H242

H302

H411

611-165-00-9

reaction mass of: tetrasodium 4-amino-6-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate;

tetrasodium 4-amino-6-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-hydroxy-3-(4-(2-sulfatoethylsulfonyl)phenylazo)naphthalene-2,7-disulfonate

431-830-5—Aquatic Chronic 3H412—H412
611-166-00-4

reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-(E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

432-100-9—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-167-00-Xsodium bis[tris(2-hydroxyethyl)ammonium][6-anilino-4'-(4,8-disulfonato-2-naphthylazo)-5'-methyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cuprate(II)435-240-9—Aquatic Chronic 3H412—H412
611-168-00-5

reaction mass of: 3-[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]-5-[[4-chloro-6-[[8-hydroxy-3,6-disulfo-7-[(2-sulfophenyl)azo]-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid;

3,5-bis[[4-chloro-6-[[7-[(1,5-disulfo-2-naphthalenyl)azo]-8-hydroxy-3,6-disulfo-1-naphthalenyl]amino]-1,3,5-triazin-2-yl]amino]benzoic acid

435-440-6—Eye Dam. 1H318

GHS05

Dgr

H318
611-169-00-0sodium 5-(2-carboxyphenylazo)-6-hydroxynaphthalene-2-sulfonate435-800-2—Aquatic Chronic 3H412—H412
611-170-00-6

reaction mass of: trisodium 2-((1-(2-hydroxy-κ-O-5-(2-sulfonatoethansulfonyl)phenylazo-κ-N2 )-1-phenylmethyl)azo-κ-N1 )-4-sulfonatobenzoate(5-)-κ-O)cuprate(II);

disodium 2-((1-(5-ethenesulfonyl-2-hydroxy-κ-O-phenylazo-κ-N2 )-1-phenylmethyl)azo-κ-N1 )-4-sulfonatobenzoate-κ-O-(5-))cuprate(II)

435-880-9—Aquatic Chronic 3H412—H412
611-171-00-1

reaction mass of: trisodium 3-(5-(2,6-difluoropyrimidin-4-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate;

trisodium 3-(5-(4,6-difluoropyrimidin-2-ylamino)-2-sulfonatophenylazo)-5-(4-fluoro-6-morpholin-4-yl-1,3,5-triazin-2-ylamino)-4-hydroxy-2,7-naphthalenedisulfonate

436-890-6—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-172-00-7

reaction mass of: triammonium 6-amino-3-((2,5-diethoxy-4-(3-phosphonophenyl)azo)phenyl)azo-4-hydroxy-2-naphthalenesulfonate;

diammonium 3-((4-((7-amino-1-hydroxy-3-sulfo-naphthalen-2-yl)azo)-2,5-diethoxyphenyl)azo)benzoate

438-310-7—

Self-react. C****

Repr. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H242

H361f***

H302

H373**

H412

GHS02

GHS08

GHS07

Dgr

H242

H361f***

H302

H373**

H412

611-173-00-2

reaction mass of: 3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, trisodium salt;

3-[3-carbamoyl-5-(5-{]4-chloro-6-[}4-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-pyridyl]propanoic acid, disodium salt

440-510-4—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-174-00-8

reaction mass of: 3-[5-(4-ethenesulfonylbutyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt;

3-[5-(4-(2-chloroethanesulfonyl)butyrylamino)-2-sulfophenylazo{]-5-4-chloro-[}6-(4-(3-amino-5-hydroxy-2,7-disulfonaphthalene-4-ylazo)-3-sulfophenylamino{]-1,3,5-triazin-2-ylamino[}-4-hydroxynaphthalene-2,7-disulfonic acid, sodium salt

442-290-5457624-86-1Eye Dam. 1H318

GHS05

Dgr

H318
611-175-00-3

reaction mass of: trisodium 5-{]4-chloro-6-[}N-ethyl-(3-(2-sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;

trisodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;

disodium 5-4-chloro-6-[}N-ethyl-3-(vinylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-4-hydroxy-3-[(4-vinylsulfonyl)phenylazo{]naphthalene-2,7-disulfonate;

tetrasodium 5-4-chloro-6-[}N-ethyl-3-(2-(sulfonatooxy)ethylsulfonyl)anilino{]-1,3,5-triazin-2-ylamino[}-3-[4-(2-(sulfonatooxy)ethylsulfonyl)phenylazo]-4-hydroxynaphthalene-2,7-disulfonate

444-050-5—

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

611-176-00-92,6-bis(2,3,4-trihydroxybenzyl)-p-cresol ester with 6-diazo-5,6-dihydro-5-oxo-1-naphthalenesulfonate444-250-2—

Self-react. C****

Aquatic Chronic 2

H242

H411

GHS02

GHS09

Dgr

H242

H411

611-177-00-4

reaction mass of: pentasodium bis[6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);

tetrasodium [6-anilino-3,5'-disulfonatonaphthalene-2-azobenzene-1,2'-diolato][6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III);

trisodium bis[6-anilino-5'-sulfamoyl-3-sulfonatonaphthalene-2-azobenzene-1,2'-diolato]cobaltate(III)

444-290-0508202-43-5

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

611-178-00-X

reaction mass of: pentasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-{](E)-2-sulfonato-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-3-{](E)-4-[}2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

tetrasodium 4-amino-5-hydroxy-6-[(E)-2-sulfonato-4-[2-(sulfonatooxy)ethylsulfonyl{]phenylazo[}-3-[(E)-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(2-hydroxyethylsulfonyl)-phenylazo]-6-[(E)-2-sulfonato-4-(vinylsulfonyl)phenylazo]naphthalene-2,7-disulfonate;

trisodium 4-amino-5-hydroxy-3-[(E)-4-(vinylsulfonyl)phenylazo]-6-[-2-sulfonato-4-(2-hydroxyethylsulfonyl)phenylazo]naphthalene-2,7-disulfonate

445-280-9—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

611-179-00-5

reaction mass of: pentasodium 2-[[8-[[4-chloro-6-[[4-(2-sulfonato ethylsulfonyl)]phenyl]amino]-1,3,5-triazin-2-yl]amino-1- hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate;

2-[[8-[[4-chloro-6-[[4-[[2-ethenyl]sulfonyl]phenyl]amino]-1,3,5-triazin-2-yl]amino]-1-hydroxy-3,6-disulfonato-2-naphthalenyl]azo]naphthalene-1,5-disulfonate

450-010-8—

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

611-180-00-0iron, complexes with diazotised 4-aminobenzenesulfonamide, diazotised 3-aminobenzenesulfonic acid, diazotised 3-amino-4-hydroxybenzenesulfonamide, diazotised 3-amino-4-hydroxy-N-phenylbenzenesulfonamide, diazotised 5-amino-2-(phenylamino)benzenesulfonic acid and resorcinol, sodium salts417-850-7—Aquatic Chronic 2H411GHS09H411
612-057-01-1

piperazine;

[liquid]

203-808-3110-85-0

Repr. 2

Skin Corr. 1B

Resp. Sens. 1

Skin Sens. 1

H361fd

H314

H334

H317

GHS05

GHS08

Dgr

H361fd

H314

H334

H317

612-122-01-4hydroxylamine …% [≤ 55 % in aqueous solution]232-259-27803-49-8

Met. Corr. 1

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

H290

H351

H312

H302

H373**

H335

H315

H318

H317

H400

GHS05

GHS08

GHS07

GHS09

Dgr

H290

H351

H312

H302

H373**

H335

H315

H318

H317

H400

B
612-169-00-3bis(N-methyl-N-phenylhydrazine)sulfate423-170-1618-26-8

Flam. Liq. 2

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H225

H372**

H302

H318

H317

H400

H410

GHS02

GHS05

GHS08

GHS07

GHS09

Dgr

H225

H372**

H302

H318

H317

H410

612-203-00-7C8-10 alkyl dimethyl hydroxyethyl ammoniumchloride (chain < C8: <3 %, chain= C8: 15 %-70 %, chain= C10: 30 %-85 %, chain > C10: <3 %)417-360-3—

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

H312

H302

H315

GHS07

Wng

H312

H302

H315

612-208-00-4 N-methylbenzene-1,2-diammonium hydrogen phosphate424-460-0—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

612-216-00-81-amino-1-cyanamino-2,2-dicyanoethylene, sodium salt425-870-219450-38-5

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

612-219-00-4(2-hydroxy-3-(3,4-dimethyl-9-oxo-10-thiaanthracen-2-yloxy)propyl)trimethylammonium chloride402-200-7—Aquatic Chronic 3H412—H412
612-220-00-X N-nitro-N-(3-methyl-3,6-dihydro-2H-1,3,5-oxadiazin-4-yl)amine431-060-1153719-38-1

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

612-221-00-52-amino-4-(trifluoromethyl)benzenethiol hydrochloride429-560-84274-38-8

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

H314

H332

H312

H302

H373**

H317

H400

GHS05

GHS08

GHS07

GHS09

Dgr

H314

H332

H312

H302

H373**

H317

H400

612-222-00-0 cis-1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinamine425-080-8104860-26-6

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H312

H302

H373**

H318

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H312

H302

H373**

H318

H410

612-223-00-6 N-benzyl-N-ethyl-(4-(5-nitro-benzo[c]isothiazol-3-ylazo)phenyl)amine425-300-2186450-73-7

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

612-224-00-1 N2,N4,N6-tris{]4-[}(1,4-dimethylpentyl)amino{]phenyl[}-1,3,5-triazine-2,4,6-triamine426-150-0121246-28-4

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

612-225-00-71,4,7,10-tetraazacyclododecane425-450-9294-90-6

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H314

H312

H302

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H312

H302

H410

612-226-00-23-(2'-phenoxyethoxy)propylamine427-870-86903-18-0

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H302

H315

H318

H412

GHS05

GHS07

Dgr

H302

H315

H318

H412

612-227-00-8benzyl-N-(2-(2-methoxyphenoxy)ethyl)amine hydrochloride428-290-8120606-08-8

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

612-228-00-3

reaction mass of: N-(3-(trimethoxysilyl)propyl)ethylenediamine;

N-benzyl-N-(3-(trimethoxysilyl)propyl)ethylenediamine;

N-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;

N,N'-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;

N,N,N'-tris-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine;

N,N-bis-benzyl-N'-[3-(trimethoxysilyl)propyl]ethylenediamine

414-340-6—

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Acute Tox. 4 *

STOT SE 2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H226

H332

H312

H302

H371

H318

H317

H412

GHS02

GHS05

GHS08

GHS07

Dgr

H226

H332

H312

H302

H371

H318

H317

H412

612-229-00-9

mepanipyrim;

4-methyl-N-phenyl-6-(1-propynyl)-2-pyrimidinamine

—110235-47-7

Carc. 2

Aquatic Acute 1

Aquatic Chronic 1

H351

H400

H410

GHS08

GHS09

Wng

H351

H410

612-230-00-4 N,N-bis(cocoyl-2-oxypropyl)-N,N-dibutylammonium bromide431-530-4—

Skin Corr. 1A

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H317

H410

612-231-00-X3-((C12-18)-acylamino)-N-(2-((2-hydroxyethyl)amino)-2-oxoethyl)-N,N-dimethyl-1-propanaminium chloride427-370-1164288-56-6

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

612-232-00-5

reaction mass of: triisopropanolamine salt of 1-amino-4-(3-propionamidoanilino)anthraquinone-2-sulfonic acid;

triisopropanolamine salt of 1-amino-4-[3,4-dimethyl-5-(2-hydroxyethylaminosulfonyl)anilino]anthraquinone-2-sulfonic acid

430-410-9186148-38-9Aquatic Chronic 3H412—H412
612-237-00-2

hydroxylammonium hydrogensulfate;

hydroxylamine sulfate(1:1); [1]

hydroxylamine phosphate; [2]

hydroxylamine dihydrogenphosphate; [3]

hydroxylamine 4-methylbenzenesulfonate [4]

233-154-4 [1]

244-077-0 [2]

242-818-2 [3]

258-872-5 [4]

10046-00-1 [1]

20845-01-6 [2]

19098-16-9 [3]

53933-48-5 [4]

Expl. 1.1

Carc. 2

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H201

H351

H312

H302

H373**

H319

H315

H317

H400

HS01

GHS08

GHS07

GHS09

Dgr

H201

H351

H312

H302

H373**

H319

H315

H317

H400

T
612-238-00-8(3-chloro-2-hydroxypropyl) trimethylammonium chloride …%222-048-33327-22-8

Carc. 2

Aquatic Chronic 3

H351

H412

GHS08

Wng

H351

H412

B
612-239-00-3

biphenyl-3,3', 4,4'-tetrayltetraamine;

diaminobenzidine

202-110-691-95-2

Carc. 1B

Muta. 2

H350

H341

GHS08

Dgr

H350

H341

612-240-00-9

pyrimethanil (ISO);

N-(4,6-dimethylpyrimidin-2-yl)aniline

—53112-28-0Aquatic Chronic 2H411GHS09H411
612-241-00-4

piperazine hydrochloride; [1]

piperazine dihydrochloride; [2]

piperazine phosphate [3]

228-042-7 [1]

205-551-2 [2]

217-775-8 [3]

6094-40-2 [1]

142-64-3 [2]

1951-97-9 [3]

Repr. 2

Eye Irrit. 2

Skin Irrit. 2

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 3

H361fd

H319

H315

H334

H317

H412

GHS08

Dgr

H361fd

H319

H315

H334

H317

H412

612-242-00-X

cyprodinil (ISO);

4-cyclopropyl-6-methyl-N-phenylpyrimidin-2-amine

—121552-61-2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M=10
612-243-00-5(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine 2-hydroxy-2-phenylacetate420-560-379617-97-3

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

M=10
612-244-00-03-(piperazin-1-yl)-benzo[d]isothiazole hydrochloride421-310-687691-88-1

Repr. 2

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H361f***

H302

H319

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H361f***

H302

H319

H317

H410

612-245-00-62-ethylphenylhydrazine hydrochloride421-460-219398-06-2

Carc. 2

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H372**

H302

H318

H317

H400

H410

GHS05

GHS08

GHS07

GHS09

Dgr

H351

H372**

H302

H318

H317

H410

M=10
612-246-00-1(2-chloroethyl)(3-hydroxypropyl)ammonium chloride429-740-640722-80-3

Carc. 1B

Muta. 1B

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H350

H340

H373**

H317

H412

GHS08

GHS07

Dgr

H350

H340

H373**

H317

H412

612-247-00-7 N-[3-(1,1-dimethylethyl)-1H-pyrazol-5-yl]-N'-hydroxy-4-nitrobenzenecarboximidamide423-530-8152828-23-4

STOT RE 1

Acute Tox. 4 *

Aquatic Chronic 3

H372**

H302

H412

GHS08

GHS07

Dgr

H372**

H302

H412

612-248-00-2reaction product of diphenylamine, phenothiazine, and alkenes, branched (C8-10, C9-rich)439-540-0—

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 4

H315

H317

H413

GHS07

Wng

H315

H317

H413

612-249-00-84-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1,2-benzenediamine dihydrochloride425-030-5159939-85-2

Repr. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H361f***

H302

H314

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H361f***

H302

H314

H317

H411

612-250-00-3chloro-N,N-dimethylformiminium chloride425-970-63724-43-4

Repr. 1B

Acute Tox. 4 *

Skin Corr. 1A

H360D***

H302

H314

GHS05

GHS08

GHS07

Dgr

H360D***

H302

H314

EUH014
612-251-00-9 cis-1-(3-chloroallyl)-3,5,7-triaza-1-azoniaadamantane chloride426-020-351229-78-8

Flam. Sol. 2

Repr. 2

Acute Tox. 4 *

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H228

H361d***

H302

H315

H317

H411

GHS02

GHS08

GHS07

GHS09

Wng

H228

H361d***

H302

H315

H317

H411

612-252-00-4

imidacloprid (ISO);

1-(6-chloropyridin-3-ylmethyl)-N-nitroimidazolidin-2-ylidenamine

428-040-8138261-41-3

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

612-253-00-X

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing < 0,5 % formamide (EC No 200-842-0)]

429-400-7199327-61-2Aquatic Chronic 3H412—H412
612-253-01-7

7-methoxy-6-(3-morpholin-4-yl-propoxy)-3H-quinazolin-4-one;

[containing ≥ 0,5 % formamide (EC No 200-842-0)]

429-400-7199327-61-2

Repr. 1B

Aquatic Chronic 3

H360D***

H412

GHS08

Dgr

H360D***

H412

612-254-00-5reaction products of diisopropanolamine with formaldehyde (1:4)432-440-8220444-73-5

Carc. 2

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H351

H302

H314

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H351

H302

H314

H317

H411

612-255-00-01-(3-methoxypropyl)-4-piperidinamine431-950-8179474-79-4

Acute Tox. 4 *

Acute Tox. 4 *

Skin Corr. 1B

Aquatic Chronic 3

H312

H302

H314

H412

GHS05

GHS07

Dgr

H312

H302

H314

H412

612-256-00-6benzyl(S)-2-[(2'-cyanobiphenyl-4-ylmethyl)pentanoylamino]-3-methylbutyrate427-470-3137864-22-3

Acute Tox. 4 *

Skin Sens. 1

H302

H317

GHS07

Wng

H302

H317

612-257-00-1tripropylammonium dihydrogenphosphate433-700-335687-90-2Acute Tox. 4 *H302

GHS07

Wng

H302
612-259-00-2 N-ethyl-3-trimethoxysilyl-2-methyl-propanamine437-720-3227085-51-0Eye Dam. 1H318

GHS05

Dgr

H318
612-261-00-33,5-dichloro-2-fluoro-4-(1,1,2,3,3,3-hexafluoropropoxy)aniline441-190-9121451-05-6

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M=10
612-265-00-5bis(2-hydroxyethyl)-(2-hydroxypropyl)ammonium acetate444-360-0191617-13-7Aquatic Chronic 3H412—H412
612-266-00-03-chloro-4-(3-fluorobenzyloxy)aniline445-590-4202197-26-0

Muta. 2

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H341

H302

H373**

H400

H410

GHS08

GHS07

GHS09

Wng

H341

H302

H373**

H410

612-267-00-6bis(hydrogenated tallow C16-18-alkyl)hydroxylamine418-370-0—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

612-269-00-7

reaction mass of: 1-[di(4-octylphenyl)aminomethyl]-5-methyl-1H-benzotriazole;

1-[di(4-octylphenyl)aminomethyl]-4-methyl-1H-benzotriazole;

reaction mass of: N-[(5-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline;

N-[(4-methyl-1H-benzotriazol-1-yl)methyl]-4-octyl-N-(4-octylphenyl)aniline

420-720-2—Aquatic Chronic 4H413—H413
612-270-00-2(S)-azetidine-2-carboxylic acid 4-cyanobenzylamide hydrochloride433-010-2—

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 3

H302

H317

H412

GHS07

Wng

H302

H317

H412

612-271-00-8

reaction mass of: ethyl 2-((4-(5,6-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate;

ethyl 2-((4-(6,7-dichlorobenzothiazol-2-ylazo)phenyl)ethylamino)benzoate

434-970-5160987-57-5Aquatic Chronic 4H413—H413
612-272-00-3ammonium (η-6-2-(2-(1,2-dicarboxylatoethylamino)ethylamino)butane-1,4-dioato(4-))iron(3+) monohydrate435-210-5—Aquatic Chronic 2H411GHS09H411
612-273-00-9alkyl(rapeseed oil), bis(2-hydroxyethyl)ammonium fluoride435-650-8—

Acute Tox. 4 *

Skin Corr. 1A

Aquatic Acute 1

Aquatic Chronic 1

H302

H314

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H314

H410

612-274-00-4(R, S)-1-[2-amino-1(4-methoxyphenyl)ethyl]cyclohexanol acetate445-750-3—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

612-275-00-Xfatty acids, C18-unsatd., dimers, reaction products with 1-piperazineethanamine and tall oil447-880-6206565-89-1

Skin Irrit. 2

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H315

H318

H317

H410

M=10
612-276-00-51-amino-4-[(4-amino-2-sulfofenyl)amino]-9,10-dihydro-9,10-dioxo-2-anthracenesulfonic acid, disodium salt, reaction products with 2-[[3-[(4,6-dichloro-1,3,5-triazin-2-yl)ethylamino]phenyl]sulfonyl]ethyl hydrogen sulfate, sodium salts451-430-4500717-36-2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

612-277-00-0

reaction mass of: 4-amino-3-(4-ethenesulfonyl-2-sulfonatophenylazo)-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)naphthalene-2,7-disulfonate potassium/sodium;

4-amino-5-hydroxy-6-(5-{]4-chloro-6-[}4-(2-sulfonatooxyethanesulfonyl)phenylamino{]-1,3,5-triazin-2-ylamino[}-2-sulfonatophenylazo)-3-(2-sulfonato-4-(2-sulfonatooxyethanesulfonyl)phenylazo)naphthalene-2,7-disulfonate potassium/sodium

451-440-9586372-44-3Eye Dam. 1H318

GHS05

Dgr

H318
612-278-00-6

ethidium bromide;

3,8-diamino-1-ethyl-6-phenylphenantridinium bromide

214-984-61239-45-8

Muta. 2

Acute Tox. 2 *

Acute Tox. 4 *

H341

H330

H302

GHS06

GHS08

Dgr

H341

H330

H302

612-279-00-1(R, S)-2-amino-3,3-dimethylbutane amide447-860-7144177-62-8

Repr. 2

STOT RE 2 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

H361f***

H373**

H319

H315

H317

GHS08

GHS07

Wng

H361f***

H373**

H319

H315

H317

612-280-00-7

3-amino-9-ethyl carbazole;

9-ethylcarbazol-3-ylamine

205-057-7132-32-1Carc. 1BH350

GHS08

Dgr

H350H
613-116-01-4

tolylfluanid (ISO);

dichloro-N-[(dimethylamino)sulphonyl]fluoro-N-(p-tolyl)methanesulphenamide;

[containing < 0,1 % (w/w) of particles with an aerodynamic diameter of below 50 μm]

211-986-9731-27-1

Eye Irrit. 2

STOT SE 3

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

H319

H335

H315

H317

H400

GHS07

GHS09

Wng

H319

H335

H315

H317

H400

M=10
613-161-00-22,4-diamino-6-hydroxymethylpteridinehydrobromide430-620-076145-91-0

STOT RE 2 *

Skin Sens. 1

Aquatic Chronic 3

H373**

H317

H412

GHS08

GHS07

Wng

H373**

H317

H412

613-162-00-8(6R-trans)-1-((7-ammonio-2-carboxylato-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct-2-en-3-yl)methyl)pyridinium iodide423-260-0100988-63-4

Muta. 2

Skin Sens. 1

Aquatic Chronic 2

H341

H317

H411

GHS08

GHS07

GHS09

Wng

H341

H317

H411

613-187-00-45-(2-amino-5-cyano-6-[2-(2-hydroxyethoxy)ethylamino]-4-methylpyridin-3-ylazo)-3-methyl-2,4-dicarbonitrilethiophene410-530-8—Skin Sens. 1H317

GHS07

Wng

H317
613-192-00-13-benzyl-exo-6-nitro-2,4-dioxo-3-aza-cis-bicyclo[3.1.0]hexane426-750-2151860-15-0

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-198-00-42-amino-4-dimethylamino-6-trifluoroethoxy-1,3,5-triazine415-500-8145963-84-4

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373**

H412

GHS08

GHS07

Wng

H302

H373**

H412

613-229-00-11-acetyl-4-(3-dodecyl-2,5-dioxo-1-pyrrolidinyl)-2,2,6,6-tetramethylpiperidine411-930-5106917-31-1

Skin Irrit. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H315

H317

H400

H410

GHS07

GHS09

Wng

H315

H317

H410

613-231-00-22,6-diamino-3-((pyridine-3-yl)azo)pyridine421-430-928365-08-4

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H302

H373**

H411

GHS08

GHS07

GHS09

Wng

H302

H373**

H411

613-232-00-83-(benzo[b]thien-2-yl)-5,6-dihydro-1,4,2-oxathiazine-4-oxide431-030-6163269-30-5

Acute Tox. 3 *

STOT RE 2 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H331

H373**

H318

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H331

H373**

H318

H410

613-234-00-9imidazo[1,2-b]pyridazin hydrochloride431-510-518087-70-2

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

613-235-00-42,3-dihydro-2,2-dimethyl-1H-perimidine424-060-66364-17-6

Acute Tox. 4*

STOT RE 2 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373**

H317

H410

613-236-00-X2-chloro-3-trifluoromethylpyridine424-520-665753-47-1

Acute Tox. 3 *

Acute Tox. 3 *

STOT RE 1

Skin Corr. 1B

Aquatic Chronic 3

H311

H301

H372**

H314

H412

GHS06

GHS05

GHS08

Dgr

H311

H301

H372**

H314

H412

613-237-00-56-tert-butyl-3-(3-dodecylsulfonyl)propyl-7H-1,2,4-triazolo[3.4b][1,3,4]thiadiazine424-950-4133949-92-5Aquatic Chronic 4H413—H413
613-238-00-0sodium 2-[[4-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]phenyl]sulfonyl]ethyl sulfate430-890-181992-66-7

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

613-239-00-62-[3-(methylamino)propyl]-1H-benzimidazole425-760-464137-52-6

Eye Dam. 1

Aquatic Chronic 3

H318

H412

GHS05

Dgr

H318

H412

613-241-00-73-(2H-tetrazol-5-yl)pyridine426-810-83250-74-6Eye Dam. 1H318

GHS05

Dgr

H318
613-242-00-2reaction products of 3,10-bis((2-aminopropyl)amino)-6,13-dichloro-4,11-triphenodioxazinedisulfonic acid with 2-amino-1,4-benzenedisulfonic acid, 2-((4-aminophenyl)sulfonyl)ethyl hydrogen sulfate and 2,4,6-trifluoro-1,3,5-triazine, sodium salts426-860-0191877-09-5Eye Dam. 1H318

GHS05

Dgr

H318
613-243-00-84,4'-(1,6-hexamethylenebis(formylimino))bis(2,2,6,6-tetramethyl-1-oxylpiperidine)427-350-0182235-14-9Aquatic Chronic 2H411GHS09H411
613-244-00-35,7-dichloro-4-hydroxyquinoline427-420-021873-52-9Aquatic Chronic 2H411GHS09H411
613-245-00-92-fluoro-6-trifluoromethylpyridine428-100-394239-04-0

Flam. Liq. 3

Acute Tox. 4 *

Acute Tox. 4 *

Aquatic Chronic 3

H226

H332

H302

H412

GHS02

GHS07

Wng

H226

H332

H302

H412

613-246-00-42-hydroxymethyl-3-methyl-4-(2,2,2-trifluoroethoxy)pyridine428-200-7103577-66-8Aquatic Chronic 3H412—H412
613-247-00-X3-(2-methoxy-4-methoxycarboxybenzyl)-5-nitroindole428-910-7107786-36-7Aquatic Chronic 4H413—H413
613-248-00-53,4-dimethyl-1H-pyrazole429-130-12820-37-3

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

613-249-00-01-(2-hydroxyethyl)-1H-pyrazol-4,5-diyldiammoniumsulfate429-300-3155601-30-2

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H318

H317

H411

GHS05

GHS07

GHS09

Dgr

H318

H317

H411

613-250-00-6

reaction mass of: carbonato-bis-N-ethyl-2-isopropyl-1,3-oxazolidine;

methyl carbonato-N-ethyl-2-isopropyl-1,3-oxazolidine;

2-isopropyl-N-hydroxyethyl 1,3-oxazolidine

429-990-6—

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H318

H317

H412

GHS05

GHS07

Dgr

H318

H317

H412

613-251-00-1(R)-3-[(1-methylpyrrolidin-2-yl)methyl]-5-[2-(phenylsulfonyl)ethenyl]-1H-indole430-560-5180637-89-2

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

H302

H373**

H318

H317

GHS05

GHS08

GHS07

Dgr

H302

H373**

H318

H317

613-253-00-2

2,2-dialkyl-4-hydroxymethyl-1,3-dioxolane;

reaction products with ethylene oxide (alkyl is C1-12 and the sum to C13, average degree of ethoxylation is 3,5)

430-580-4—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

EUH019
613-254-00-8

forchlorfenuron (ISO);

1-(2-chloro-4-pyridyl)-3-phenylurea

—68157-60-8

Carc. 2

Aquatic Chronic 2

H351

H411

GHS08

GHS09

Wng

H351

H411

613-255-00-3reaction mass of isomers of: sodium [(2-hydroxyethylsulfamoyl){][}2-(2-piperazin-1-ylethylamino)ethylsulfamoyl][2-(4-aminoethylpiperazine-1-yl)ethylsulfamoyl{](sulfamoyl)[}(sulfonatophthalocyaninato)]copper(II)424-270-8—Eye Dam. 1H318

GHS05

Dgr

H318
613-256-00-93'5'-anhydro thymidine425-810-538313-48-3Aquatic Chronic 3H412—H412
613-257-00-42-phthalimidoethyl N-[4-(2-cyano-4-nitrophenylazo)phenyl]-N-methyl-β-alaninate426-400-9170222-39-6

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

613-258-00-X

reaction mass of: 4-chloro-7-methylbenzotriazole sodium salt;

4-chloro-5-methylbenzotriazole sodium salt;

5-chloro-4-methylbenzotriazole sodium salt

427-730-6202420-04-0

Skin Corr. 1B

Aquatic Chronic 3

H314

H412

GHS05

Dgr

H314

H412

613-259-00-5

reaction mass of: [2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-cis-chrysanthemate;

[2,4-dioxo-(2-propyn-1-yl)imidazolidin-3-yl]methyl(1R)-trans-chrysanthemate

428-790-672963-72-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

613-260-00-0(±)-4-(3-chlorophenyl)-6-[(4-chlorophenyl)hydroxy(1-methyl-1H-imidazol-5-yl)methyl]-1-methyl-2(1H)-quinolin430-730-9—

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H400

H410

GHS05

GHS09

Dgr

H318

H410

613-261-00-6pyrazole-1-carboxamidine monohydrochloride429-520-14023-02-3

Acute Tox. 4 *

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H373**

H318

H317

H412

GHS05

GHS08

GHS07

Dgr

H302

H373**

H318

H317

H412

613-262-00-1disodium (E)-1,2-bis-(4-(4-methylamino-6-(4-methylcarbamoylphenylamino)-1,3,5-triazin-2-ylamino)phenyl-2-sulfonato)ethene427-310-2180850-95-7Eye Dam. 1H318

GHS05

Dgr

H318
613-263-00-7monosodium 3-cyano-5-fluoro-6-hydroxypyridine-2-olate429-570-2—Skin Sens. 1H317

GHS07

Wng

H317
613-266-00-32-chloro-5-chloromethylthiazole429-830-5105827-91-6

Acute Tox. 3 *

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H311

H314

H302

H317

H411

GHS06

GHS05

GHS09

Dgr

H311

H314

H302

H317

H411

613-267-00-9

thiamethoxam (ISO);

3-(2-chloro-thiazol-5-ylmethyl)-5-methyl[1,3,5]oxadiazinan-4-ylidene-N-nitroamine

428-650-4153719-23-4

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M=10
613-268-00-4(4aS-cis-)-6-benzyl-octahydropyrrolo[3.4-b]pyridine425-930-8151213-39-7

Skin Corr. 1B

Acute Tox. 4 *

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 2

H314

H332

H302

H373**

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H314

H332

H302

H373**

H411

613-269-00-X2-thiazolidinylidenecyanamide427-720-126364-65-8

Acute Tox. 4*

STOT RE 2 *

Aquatic Chronic 3

H302

H373**

H412

GHS08

GHS07

Wng

H302

H373**

H412

613-270-00-55-amino-N-(2,6-dichloro-3-methylphenyl)-1H-1,2,4-triazole-3-sulfonamide428-150-6113171-13-4Aquatic Chronic 3H412—H412
613-271-00-0

tritosulfuron (ISO) (containing ≤ 0,02 % AMTT);

1-[4-methoxy-6-(trifluoromethyl)-1,3,5-triazin-2-yl]-3-[2-(trifluoromethyl)benzenesulfonyl]urea (containing ≤ 0,02 % AMTT)

—142469-14-5

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M=10
613-272-00-6

pyraclostrobin (ISO);

methyl N-{]2-[}1-(4-chlorophenyl)-1H-pyrazol-3-yloxymethyl{]phenyl[}(N-methoxy)carbamate

——

Acute Tox. 3 *

Skin Irrit. 2

Aquatic Acute 1

Aquatic Chronic 1

H331

H315

H400

H410

GHS06

GHS09

Dgr

H331

H315

H410

M=100
613-273-00-1tetrahydro-3-methyl-5-((2-phenylthio)thiazol-5-ylmethyl)-[4H]-1,3,5-oxadiazinan-4-ylidene-N-nitroamine427-600-9192439-46-6Aquatic Chronic 2H411GHS09H411
613-274-00-72,6-dichloro-1-fluoropyridiniumtetrafluoroborate427-400-1140623-89-8

Skin Corr. 1B

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H314

H302

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H314

H302

H317

H410

613-275-00-23-(2-chloroethyl)-6,7,8,9-tetra-hydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one monohydrochloride424-530-093076-03-0

Acute Tox. 3 *

STOT SE 2

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H301

H371**

H373**

H318

H317

H411

GHS06

GHS05

GHS08

GHS09

Dgr

H301

H371

H373**

H318

H317

H411

613-276-00-81-(2-chlorophenyl)-1,2-dihydro-5H-tetrazol-5-one426-110-298377-35-6

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-277-00-3(4-(6-diethylamino-2-methylpyridin-3-yl)imino-4,5-dihydro-3-methyl-1-(4-methylphenyl)-1H-pyrazol-5-one427-070-9—Aquatic Chronic 4H413—H413
613-278-00-9(3-aminophenyl)pyridin-3-ylmethanone428-230-079568-06-2

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373**

H400

H410

GHS08

GHS09

Wng

H373**

H410

613-279-00-42-ethyl-2,3-dihydro-2-methyl-1H-perimidine424-380-643057-68-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373**

H410

613-280-00-X

tetrahydro-1,3-dimethyl-1H-pyrimidin-2-one;

dimethyl propyleneurea

230-625-67226-23-5

Repr. 2

Acute Tox. 4 *

Eye Dam. 1

H361f***

H302

H318

GHS05

GHS08

GHS07

Dgr

H361f***

H302

H318

613-281-00-5quinoline202-051-691-22-5

Carc. 1B

Muta. 2

Acute Tox. 4 *

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Aquatic Chronic 2

H350

H341

H312

H302

H319

H315

H411

GHS08

GHS07

GHS09

Dgr

H350

H341

H312

H302

H319

H315

H411

613-282-00-0

triticonazole (ISO);

(RS)-(E)-5-(4-chlorobenzylidene)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-methyl)cyclopentanol

—131983-72-7Aquatic Chronic 2H411GHS09H411
613-283-00-6

ketoconazole;

1-[4-[4-[[(2SR, 4RS)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone

265-667-465277-42-1

Repr. 1B

Acute Tox. 3 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H360F***

H301

H373**

H400

H410

GHS06

GHS08

GHS09

Dgr

H360F***

H301

H373**

H410

613-284-00-1

metconazole (ISO);

(1RS, 5RS;1RS, 5SR)-5-(4-chlorobenzyl)-2,2-dimethyl-1-(1H-1,2,4-triazol-1-ylmethyl)cyclopentanol

—125116-23-6

Repr. 2

Acute Tox. 4 *

Aquatic Chronic 2

H361d***

H302

H411

GHS08

GHS07

GHS09

Wng

H361d***

H302

H411

613-285-00-7

1-hydroxybenzotriazole, anhydrous; [1]

1-hydroxybenzotriazole, monohydrated [2]

219-989-7 [1]

219-989-7 [2]

2592-95-2 [1]

123333-53-9 [2]

Expl. 1.3H203

GHS01

Dgr

H203
613-286-00-2

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing < 0,5 % N,N-dimethylformamide (EC no 200-679-5)]

418-260-2183196-57-8Skin Sens. 1H317

GHS07

Wng

H317
613-286-01-X

potassium 1-methyl-3-morpholinocarbonyl-4-[3-(1-methyl-3-morpholinocarbonyl-5-oxo-2-pyrazolin-4-ylidene)-1-propenyl]pyrazole-5-olate;

[containing ≥ 0,5 % N,N-dimethylformamide (EC No 200-679-5)]

418-260-2183196-57-8

Repr. 1B

Skin Sens. 1

H360D***

H317

GHS08

GHS07

Dgr

H360D***

H317

613-287-00-81-(3-iodo-4-aminobenzyl)-1H-1,2,4-triazole419-540-7160194-26-3

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

613-288-00-31,3-bis(dimethylcarbamoyl)-imidazolium chloride420-930-4135756-61-5

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

613-289-00-93-(4-chloro-2-fluoro-5-methylphenyl)-1-methyl-5-(trifluoromethyl)-1H-pyrazole432-020-4142623-48-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
613-290-00-44-hydroxy-7-(2-aminoethyl)-1,3-benzothiazol-2(3H)-one hydrochloride432-470-1189012-93-9

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H318

H317

H410

613-291-00-X2,4-dihydro-4-(4-(4-(4-hydroxyphenyl)-1-piperazinyl)phenyl)-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one434-820-9106461-41-0

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H373**

H400

H410

GHS08

GHS09

Wng

H373**

H410

613-292-00-5 N,N',N''-tris(2-methyl-2,3-epoxypropyl)-perhydro-2,4,6-oxo-1,3,5-triazine435-010-826157-73-3

Muta. 2

Aquatic Chronic 3

H341

H412

GHS08

Wng

H341

H412

613-293-00-02-(4-tert-butylphenyl)-6-cyano-5-[bis(ethoxycarbonylmethyl)carbamoyloxy]-1H-pyrrolo[1,2-b][1,2,4] triazole-7-carboxylic acid 2,6-di-tert-butyl-4-methylcyclohexylester448-050-6444065-11-6Aquatic Chronic 4H413—H413
613-294-00-62-hexyldecanoic acid [4-(6-tert-butyl-7-chloro-1H-pyrazolo[1,5-b][1,2,4]triazol-2-yl)phenylcarbamoyl]methylester448-260-8379268-96-9Aquatic Chronic 4H413—H413
613-295-00-111-amino-3-chloro-6,11-dihydro-5,5-dioxo-6-methyl-dibenzo[c, f][1,2]thiazepine hydrochloride448-720-8363138-44-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

613-296-00-7pentapotassium 2-(4-(5-[1-(2,5-disulfonatophenyl)-4,5-dihydro-3-methylcarbamoyl-5-oxopyrazol-4-ylidene]-3-methyl-1,3-pentadienyl)-3-methylcarbamoyl-5-oxidopyrazol-1-yl)benzene-1,4-disulfonate418-270-7—

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

613-297-00-25-(2-bromophenyl)-2-tert-butyl-2H-tetrazole420-820-6—

Flam. Liq. 3

Acute Tox. 4 *

Aquatic Chronic 2

H226

H302

H411

GHS02

GHS07

GHS09

Wng

H226

H302

H411

613-298-00-8bis-(6-hydroxy-4-methyl-5-(3-methylimidazolium-1-yl)-3-(4-phenylazo)-1H-pyridin-2-one)ethylene dilactate421-560-6—

STOT RE 2 *

Eye Dam. 1

Aquatic Chronic 2

H373**

H318

H411

GHS05

GHS08

GHS09

Dgr

H373**

H318

H411

613-299-00-3

main component 1 (isomer 1): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonapht-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;

main component 1 (isomer 2): 2-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-3-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;

main component 2: 2,3-bis-{]6-fluoro-4-[}3-(2,5-disulfo-phenylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt;

main component 3: 2,3-bis-{]6-fluoro-4-[}3-(1,5-disulfonaphth-2-ylazo)-4-hydroxy-2-sulfonaphth-7-ylamino{]-1,3,5-triazin-2-ylamino[}-propane sodium salt

422-610-1—Eye Dam. 1H318

GHS05

Dgr

H318
613-300-00-71-imidazol-1-yl-octadecan-2-ol434-120-3—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

613-301-00-2dimethyl-1-{][}2-methoxy-5-(2-methyl-butoxycarbonyl)phenylcarbamoyl]-[2-octadecyl-1,1-dioxo-1,2,4-benzothiadiazin-3-yl{]methyl[} imidazole-4,5-dicarboxylate443-910-7—Aquatic Chronic 4H413—H413
613-302-00-8disodium 2-(5-carbamoyl-1-ethyl-2-hydroxy-4-methyl-6-oxo-1,6-dihydro-pyridine-3-ylazo)-4-(4-fluoro-6-(4-(2-sulfonyloxy-ethylsulfonyl)-phenylamino)-1,3,5-triazine-2-ylamino)benzene sulfonate432-980-4243858-60-8Eye Dam. 1H318

GHS05

Dgr

H318
613-303-00-32-(1-methyl-2-(4-phenoxyphenoxy)ethoxy)pyridine429-800-195737-68-1

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
613-304-00-95,6-dihydroxy-2,3-dihydro-1H-indolium bromide421-170-6138937-28-7

Acute Tox. 4 *

Eye Dam. 1

H302

H318

GHS05

GHS07

Dgr

H302

H318

613-305-00-42-(2-hydroxy-4-octyloxyphenyl)-2H-benzotriazole448-630-93147-77-1Aquatic Chronic 4H413—H413
613-306-00-X(2,5-dioxopyrrolidin-1-yl)-9H-fluoren-9-ylmethyl carbonate433-520-582911-69-1

Acute Tox. 4 *

Skin Sens. 1

Aquatic Chronic 2

H302

H317

H411

GHS07

GHS09

Wng

H302

H317

H411

613-307-00-5

clothianidin (ISO);

3-[(2-chloro-1,3-thiazol-5-yl)methyl]-2-methyl-1-nitroguanidine

—210880-92-5

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H400

H410

GHS07

GHS09

Wng

H302

H410

M=10
613-308-00-02-amino-5-methylthiazole423-800-57305-71-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Acute 1

Aquatic Chronic 1

H302

H373**

H400

H410

GHS08

GHS07

GHS09

Wng

H302

H373**

H410

613-309-00-61-methyl-3-phenyl-1-piperazine431-180-25271-27-2

Acute Tox. 4 *

Acute Tox. 4 *

Skin Irrit. 2

Eye Dam. 1

Aquatic Chronic 3

H312

H302

H315

H318

H412

GHS05

GHS07

Dgr

H312

H302

H315

H318

H412

613-310-00-1(-)(3S, 4R)-4-(4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-N-benzylpiperidine hydrochloride432-360-3105813-13-6

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

613-311-00-7methyl-5-nitrophenyl-guanidine435-500-1152460-07-6

Acute Tox. 4 *

Eye Irrit. 2

Skin Sens. 1

Aquatic Chronic 3

H302

H319

H317

H412

GHS07

Wng

H302

H319

H317

H412

613-312-00-22-(4-methyl-2-phenyl-1-piperazinyl)benzenemethanol monohydrochloride420-200-5—

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

613-313-00-82-(4-(4-(3-pyridinyl)-1H-imidazol-1-yl)butyl)-1H-isoindole-1,3(2H)-dione442-780-9173838-67-0Aquatic Chronic 3H412—H412
613-314-00-3

4-decyloxazolidin-2-one;

4-decyl-1,3-oxazolidin-2-one

443-770-77693-82-5

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
613-315-00-9tetrapotassium 4-[5-[3-carboxylato-4,5-dihydro-5-oxo-1-(4-sulfonatophenyl)pyrazol-4-ylidene]-3-(piperidinocarbonyl)penta-1,3-dienylidene]-5-hydroxy-1-(4-sulfonatophenyl)pyrazole-3-carboxylate430-390-1—

Acute Tox. 4 *

Aquatic Chronic 3

H332

H412

GHS07

Wng

H332

H412

613-316-00-4

trimethylopropane tri(3-aziridinylpropanoate);

(TAZ)

257-765-052234-82-9

Muta. 2

Eye Dam. 1

Skin Sens. 1

H341

H318

H317

GHS05

GHS08

GHS07

Dgr

H341

H318

H317

H
615-033-00-1reaction product of diphenylmethanediisocyanate, octylamine, oleylamine and cyclohexylamine (1:1.58:0.32:0097)430-980-9—Aquatic Chronic 4H413—H413
615-034-00-7reaction product of diphenylmethanediisocyanate, octylamine, 4-ethoxyaniline and ethylenediamine (1:0,37:1,53:0,05)430-750-8—Aquatic Chronic 4H413—H413
615-035-00-2reaction product of diphenylmethanediisocyanate, octylamine and oleylamine (molar ratio 1:1.86:0.14)430-930-6122886-55-9Aquatic Chronic 4H413—H413
615-036-00-8reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 4:1:7:1:2)430-940-0—Aquatic Chronic 4H413—H413
615-037-00-3reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine and oleylamine (molar ratio 4:1:9:1)430-950-5—Aquatic Chronic 4H413—H413
615-038-00-9reaction product of toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate) and aniline (molarratio 1:2)430-960-1—Aquatic Chronic 4H413—H413
615-039-00-4reaction product of diphenylmethanediisocyanate, toluenediisocyanate (reaction mass of isomers: 65 % 2,4- and 35 % 2,6-diisocyanate), octylamine, oleylamine and 4-ethoxyaniline (molar ratio 3.88:1:6.38:0.47:2.91)430-970-4—Aquatic Chronic 4H413—H413
615-044-00-14-chlorophenylisocyanate203-176-9104-12-1

Acute Tox. 2 *

Acute Tox. 4 *

STOT SE 3

Skin Irrit. 2

Eye Dam. 1

Resp. Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H330

H302

H335

H315

H318

H334

H400

H410

GHS06

GHS05

GHS08

GHS09

Dgr

H330

H302

H335

H315

H318

H334

H410

615-045-00-74,4'-methylene bis(3-chloro-2,6-di-ethylphenylisocyanate)420-530-1—

Resp. Sens. 1

Skin Sens. 1

Aquatic Chronic 4

H334

H317

H413

GHS08

Dgr

H334

H317

H413

616-107-00-6

cinidon ethyl (ISO);

ethyl (Z)-2-chloro-3-[2-chloro-5-(cyclohex-1-ene-1,2-dicarboximido)phenyl]acrylate

—142891-20-1

Carc. 2

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H351

H317

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H317

H410

616-122-00-8methylneodecanamide414-460-9105726-67-8Acute Tox. 4 *H302

GHS07

Wng

H302
616-126-00-X1-methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxamide423-960-6139756-01-7

Acute Tox. 4 *

STOT RE 2 *

Aquatic Chronic 3

H302

H373**

H412

GHS08

GHS07

Wng

H302

H373**

H412

616-131-00-71-aminocyclopentanecarboxamide422-950-917193-28-1

STOT RE 1

Acute Tox. 4 *

Eye Dam. 1

H372**

H302

H318

GHS05

GHS08

GHS07

Dgr

H372**

H302

H318

616-136-00-4reaction product of cocoalkyldiethanolamides and cocoalkylmonoglycerides and molybdenumtrioxide (1.75-2.2: 0.75-1.0:0.1-1.1)430-380-7—Aquatic Chronic 2H411GHS09H411
616-137-00-X4-dichloroacetyl-1-oxa-4-azaspiro[4.5]decane401-130-471526-07-3

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-138-00-5benzoic acid, N-tert-butyl-N'-(4-chlorobenzoyl)hydrazide431-600-4112226-61-6

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-139-00-0(3S, 4aS, 8aS)-N-tert-butyldecahydro-3-isoquinolinecarboxamide420-380-5136465-81-1

Acute Tox. 4 *

Eye Dam. 1

Aquatic Chronic 3

H302

H318

H412

GHS05

GHS07

Dgr

H302

H318

H412

616-140-00-6 N,N''-(methylenedi-4,1-phenylene)bis[N'-(4-methylphenyl)urea]429-380-1133336-92-2

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-141-00-1

zoxamide (ISO);

(RS)-3,5-dichloro-N-(3-chloro-1-ethyl-1-methyl-2-oxopropyl)-p-toluamide

—156052-68-5

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H317

H400

H410

GHS07

GHS09

Wng

H317

H410

M=10
616-144-00-83,4-dichloro-N-[5-chloro-4-[2-[4-dodecyloxyphenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide431-130-1—Aquatic Chronic 4H413—H413
616-145-00-3

pethoxamide (ISO);

2-chloro-N-(2-ethoxyethyl)-N-(2-methyl-1-phenylprop-1-enyl)acetamide

—106700-29-2

Acute Tox. 4 *

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H302

H317

H400

H410

GHS07

GHS09

Wng

H302

H317

H410

M=100
616-146-00-9 N-(2-methoxy-5-octadecanoylaminophenyl)-2-(3-benzyl-2,5-dioxoimidazolidin-1-yl)-4,4-dimethyl-3-oxopentanoic acidamide431-330-7142776-95-2Aquatic Chronic 4H413—H413
616-147-00-41-methyl-4-(2-methyl-2H-tetrazol-5-yl)-1H-pyrazole-5-sulfonamide424-160-1139481-22-4

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-148-00-X N-[6,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6-oxo-1H-purin-2-yl]acetamide424-550-184245-12-5

Carc. 1B

Muta. 1B

Repr. 1B

H350

H340

H360FD

GHS08

Dgr

H350

H340

H360FD

616-150-00-0(2R, 3S)-N-(3-amino-2-hydroxy-4-phenylbutyl)-N-isobutyl-4-nitrobenzenesulfonamide hydrochloride425-260-6—

STOT RE 2 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 2

H373**

H318

H317

H411

GHS05

GHS08

GHS07

GHS09

Dgr

H373**

H318

H317

H411

616-151-00-6 N-(2-amino-4,6-dichloropyrimidin-5-yl)formamide425-650-6171887-03-9

Acute Tox. 4 *

Eye Dam. 1

Skin Sens. 1

Aquatic Chronic 3

H302

H318

H317

H412

GHS05

GHS07

Dgr

H302

H318

H317

H412

616-152-00-14-(4-fluorophenyl)-2-(2-methyl-1-oxopropyl)-4-oxo-3,N-diphenylbutanamide425-850-3125971-96-2Aquatic Chronic 4H413—H413
616-153-00-74-methyl-3-oxo-N-phenyl-2-(phenylmethylene)pentanamide425-860-8125971-57-5

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-154-00-23,4-dichloro-N-[5-chloro-4-[2-[4-(hexadecyloxy)phenylsulfonyl]butyramido]-2-hydroxyphenyl]benzamide431-110-0—Aquatic Chronic 4H413—H413
616-155-00-8 N,N,N',N'-tetracyclohexyl-1,3-benzenedicarboxamide431-040-0104560-40-9

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
616-156-00-36-(2-chloro-6-cyano-4-nitrophenylazo)-4-methoxy-3-[N-(methoxycarbonylmethyl)-N-(1-methoxycarbonylethyl)amino]acetanilide430-500-8204277-61-2Aquatic Chronic 4H413—H413
616-157-00-93-amino-4-hydroxy-N-(3-isopropoxypropyl)benzenesulfonamide hydrochloride427-780-9114565-70-7

Acute Tox. 4 *

Eye Dam. 1

Aquatic Acute 1

Aquatic Chronic

H302

H318

H400

H410

GHS05

GHS07

GHS09

Dgr

H302

H318

H410

616-158-00-4 N-[4-cyano-3-trifluoromethylphenyl]methacrylamide427-880-290357-53-2

STOT RE 2 *

Aquatic Chronic 2

H373**

H411

GHS08

GHS09

Wng

H373**

H411

616-160-00-52,2'-azobis[N-(2-hydroxyethyl)-2-methylpropionamide]429-090-361551-69-7

Skin Sens. 1

Aquatic Chronic 3

H317

H412

GHS07

Wng

H317

H412

616-161-00-02,4-dichloro-5-hydroxyacetanilide429-110-067669-19-6Aquatic Chronic 3H412—H412
616-162-00-6isostearic acid monoisopropanolamide431-540-9—

Skin Irrit. 2

Aquatic Chronic 2

H315

H411

GHS07

GHS09

Wng

H315

H411

616-163-00-14,4'-methylenebis[N-(4-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide]430-350-3192463-88-0Aquatic Chronic 4H413—H413
616-164-00-7

dimoxystrobin (ISO);

(E)-2-(methoxyimino)-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide

—149961-52-4

Carc. 2

Repr. 2

Acute Tox. 4 *

Aquatic Acute 1

Aquatic Chronic 1

H351

H361d***

H332

H400

H410

GHS08

GHS07

GHS09

Wng

H351

H361d***

H332

H410

M=10
616-165-00-2

beflubutamid (ISO);

(RS)-N-benzyl-2-(α, α, α, 4-tetrafluoro-m-tolyoxy)butyramide

—113614-08-7

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410M=100
616-166-00-8

cyazofamid (ISO);

4-chloro-2-cyano-N,N-dimethyl-5-p-tolylimidazole-1-sulfonamide

—120116-88-3

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410M=10
616-167-00-3 N,N-dibutyl-(2,5-dihydro-5-thioxo-1H-tetrazol-1-yl)acetamide418-290-6168612-06-4

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

616-168-00-91-dimethylcarbamoyl-4-(2-sulfonatoethyl)pyridinium418-440-0136997-71-2Skin Sens. 1H317

GHS07

Wng

H317
616-169-00-44-[4-(2,2-dimethyl-propanamido)]phenylazo-3-(2-chloro-5-(2-(3-pentadecylphenoxy)butylamido)anilino)-1-(2,4,6-trichlorophenyl)-2-pyrazoline-5-one420-220-492771-56-7

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-170-00-X(2R)-2-amino-2-phenylacetamide420-370-06485-67-2

Eye Irrit. 2

Skin Sens. 1

H319

H317

GHS07

Wng

H319

H317

616-171-00-52-(para-chlorophenyl)glycineamide420-830-0102333-75-5

Eye Dam. 1

Skin Sens. 1

H318

H317

GHS05

GHS07

Dgr

H318

H317

616-172-00-0

N-(2,2,6,6-tetramethyl-1-oxylpiperidin-4-yl)acetamide;

(4-acetamido-2,2,6,6-tetramethyl-1-piperidinyl)oxidanyl

423-840-314691-89-5Acute Tox. 4 *H302

GHS07

Wng

H302
616-174-00-12-butyl-1,3-diazaspiro[4.4]non-1-en-4-one hydrochloride424-560-4151257-01-1

Acute Tox. 4 *

Eye Irrit. 2

H302

H319

GHS07

Wng

H302

H319

616-175-00-72-(2-hexyldecyloxy)benzamide431-230-3202483-62-3Aquatic Chronic 4H413—H413
616-176-00-23-N,N-bis(methoxyethyl)aminoacetanilide432-530-724294-01-7

Acute Tox. 4 *

Aquatic Chronic 3

H302

H412

GHS07

Wng

H302

H412

616-177-00-8

(3-(4-(2-(butyl-(4-methylphenylsulfonyl)amino)phenylthio)-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazole-3-ylamino)-4-chlorophenyl)tetradecanamide;

N-[3-({]4-[}(2-{]butyl[}(4-methylphenyl)sulfonyl{]amino[}phenyl)thio{]-5-oxo-1-(2,4,6-trichlorophenyl)-4,5-dihydro-1H-pyrazol-3-yl[}amino)-4-chlorophenyl]tetradecanamide

432-970-1217324-98-6Aquatic Chronic 4H413—H413
616-178-00-3 N-(5-(bis(2-methoxyethyl)amino)-2-((2-cyano-4,6-dinitrophenyl)-azo)phenyl)acetamide434-500-952583-35-4Aquatic Chronic 4H413—H413
616-179-00-92-chloro-N-(4-methylphenyl)acetamide435-170-916634-82-5

Eye Dam. 1

Skin Sens. 1

Aquatic Acute 1

Aquatic Chronic 1

H318

H317

H400

H410

GHS05

GHS07

GHS09

Dgr

H318

H317

H410

616-180-00-4 N,N-(dimethylamino)thioacetamide hydrochloride435-470-127366-72-9

Repr. 1B

Aquatic Acute 1

Aquatic Chronic 1

H360D***

H400

H410

GHS08

GHS09

Dgr

H360D***

H410

616-181-00-X4'-methyldodecane-1-sulfonanilide435-490-917417-32-2

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
616-182-00-5 N'-(1,3-dimethylbutylidene)-3-hydroxy-2-naphthohydrazide435-860-1214417-91-1

Skin Sens. 1

Aquatic Chronic 2

H317

H411

GHS07

GHS09

Wng

H317

H411

616-183-00-0 N-dodecyl-4-methoxybenzamide442-340-61854-15-5Aquatic Chronic 4H413—H413
616-184-00-63-methyl-N-(5,8,13,14-tetrahydro-5,8,14-trioxonaphth[2,3-c]acridin-6-yl)benzamide442-560-2105043-55-8Aquatic Chronic 4H413—H413
616-186-00-7 N,N'-(2-chloro-1,4-phenylene)bis(3-oxobutaneamide)443-010-453641-10-4Aquatic Chronic 3H412—H412
616-188-00-82-(5,5-dimethyl-2,4-dioxooxazolidin-3-yl)-4,4-dimethyl-3-oxo-N-(2-methoxy-5-octadecanoylaminophenyl)pentanoic acid amide443-980-9221215-20-9

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-189-00-3 N-[5-(bis-(2-methoxy-ethyl)-amino]-2-(6-bromo-2-methyl-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-phenyl]acetamide444-780-4452962-97-9Aquatic Chronic 4H413—H413
616-190-00-9 N-decyl-4-nitrobenzamide445-880-064026-19-3Aquatic Chronic 4H413—H413
616-191-00-42-ethyl-N-methyl-N-(3-methylphenyl)butanamide446-190-2406488-30-0

Acute Tox. 4 *

Eye Irrit. 2

Skin Irrit. 2

Skin Sens. 1

Aquatic Chronic 2

H302

H319

H315

H317

H411

GHS07

GHS09

Wng

H302

H319

H315

H317

H411

616-192-00-X2-[2-(3-butoxypropyl)-1,1-dioxo-1,2,4-benzothiadiazin-3-yl]-5'-tert-butyl-2-(5,5-dimethyl-2,4-dioxo-1,3-oxazolidin-3-yl)-2'-[(2-ethylhexyl)thio]acetanilide448-060-0727678-39-9Aquatic Chronic 4H413—H413
616-193-00-5 N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)-5-diethylamino-phenyl]acetamide449-940-7368450-39-9Aquatic Chronic 4H413—H413
616-194-00-02,2-diethoxy-N,N-dimethylacetamide449-950-134640-92-1Eye Irrit. 2H319

GHS07

Wng

H319
616-196-00-1disodium salt of 1-hydroxy-4-(β-(4-(1-hydroxy-3,6-disulfo-8-acetylamino-2-naphthylazo)phenoxy)ethoxy)-N-dodecyl-2-naphthamide419-990-4—

Aquatic Acute 1

Aquatic Chronic 1

H400

H410

GHS09

Wng

H410
616-197-00-7

reaction mass of: potassium N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamidate;

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluorooctane sulfonamide

422-500-1—STOT RE 2 *H373**

GHS08

Wng

H373**
616-198-00-21,3-bis[12-hydroxy-octadecamide-N-methylene]-benzene423-300-7—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-200-00-1

reaction mass of: N,N'-ethane-1,2-diylbis(hexanamide);

12-hydroxy-N-[2-[(1-oxyhexyl)amino]ethyl]octadecanamide;

N,N'-ethane-1,2-diylbis(12-hydroxyoctadecanamide)

432-430-3—

Skin Sens. 1

Aquatic Chronic 4

H317

H413

GHS07

Wng

H317

H413

616-201-00-712-hydroxyoctadecanoic acid, reaction products with 1,3-benzenedimethanamine and hexamethylenediamine432-840-2220926-97-6

Acute Tox. 4 *

Aquatic Chronic 4

H332

H413

GHS07

Wng

H332

H413

616-202-00-2

reaction mass of: 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(azo)]bis[N-(2,4-dimethylphenyl)]-3-oxo-butanamide;

2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-methylphenyl)-3-oxo-butanamide;

2-[[3,3'-dichloro-4'-[[1[[(2,4-dimethylphenyl)amino]carbonyl]-2-oxopropyl]azo][1,1'-biphenyl]-4-yl]azo]-N-(2-carboxylphenyl)-3-oxo-butanamide

434-330-5—

Carc. 2

Skin Sens. 1

Aquatic Chronic 4

H351

H317

H413

GHS08

GHS07

Wng

H351

H317

H413

616-203-00-8

reaction mass of: N-[5-[bis-(2-methoxyethyl)amino]-2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-yl-azo)phenyl]acetamide;

N-[2-(2-butyl-4,6-dicyano-1,3-dioxo-2,3-dihydro-1H-isoindol-5-ylazo)5-diethylaminophenyl]acetamide

442-280-0—Aquatic Chronic 4H413—H413
616-204-00-3 N,N''-(methylenedi-4,1-phenylene)bis[N'-octylurea]451-060-3122886-55-9Aquatic Chronic 4H413—H413
617-021-00-1methylethylketone peroxide trimer429-320-2—

Org. Perox. B****

Asp. Tox. 1

Skin Irrit. 2

Skin Sens. 1

H241

H304

H315

H317

GHS01

GHS02

GHS08

GHS07

Dgr

H241

H304

H315

H317

617-022-00-7

reaction mass of: 1,2-dimethylpropylidene dihydroperoxide;

dimethyl 1,2-benzenedicarboxylate

442-480-8—

Org. Perox. C

Acute Tox. 4 *

Skin Corr. 1B

Skin Sens. 1

Aquatic Chronic 2

H242

H302

H314

H317

H411

GHS02

GHS05

GHS07

GHS09

Dgr

H242

H302

H314

H317

H411

647-017-00-5laccase420-150-480498-15-3Resp. Sens. 1H334

GHS08

Dgr

H334